Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
42000,See Activity_Supp For Individual Animal Data,17423046,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,BASOLE,%,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,BASOPHIL,%,UO_0000187,0.0
42001,See Activity_Supp For Individual Animal Data,17423047,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,EOSLE,%,0.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,EOSINOPHIL,%,UO_0000187,0.33
42002,See Activity_Supp For Individual Animal Data,17423048,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,RBC,cells.uL-1,5260000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,ERYTHROCYTE COUNT,x10E6/uL,,5.26
42003,See Activity_Supp For Individual Animal Data,17423049,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,HCT,%,34.07,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,HEMATOCRIT,%,UO_0000187,34.07
42004,See Activity_Supp For Individual Animal Data,17423050,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,HGB,ug.mL-1,137300.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,HEMOGLOBIN,G/DL,UO_0000274,13.73
42005,See Activity_Supp For Individual Animal Data,17423051,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,WBC,cells.uL-1,13070.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,LEUKOCYTE COUNT,x10E3/uL,,13.07
42006,See Activity_Supp For Individual Animal Data,17423052,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,LYMLE,%,92.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,LYMPHOCYTE,%,UO_0000187,92.0
42007,See Activity_Supp For Individual Animal Data,17423053,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,MCH,pg,26.17,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,26.17
42008,See Activity_Supp For Individual Animal Data,17423054,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,MCHC,ug.mL-1,403000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,40.3
42009,See Activity_Supp For Individual Animal Data,17423055,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,MCV,fL,64.87,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,MEAN CORPUSCULAR VOLUME,FL,,64.87
42010,See Activity_Supp For Individual Animal Data,17423056,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,MONOLE,%,1.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,MONOCYTE,%,UO_0000187,1.67
42011,See Activity_Supp For Individual Animal Data,17423057,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,NEUTLE,%,6.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,NEUTROPHIL,%,UO_0000187,6.0
42012,See Activity_Supp For Individual Animal Data,17423058,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,RBCNUC,/100WBC,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,NUCLEATED RED BLOOD CELLS,/100WBC,,0.0
42013,See Activity_Supp For Individual Animal Data,17423059,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,PLAT,cells.uL-1,1216330.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11974.0,PLATELET COUNT,x10E3/uL,,1216.33
42014,See Activity_Supp For Individual Animal Data,17423060,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,ALT,U.L-1,69.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,ALANINE AMINOTRANSFERASE,u/L,,69.0
42015,See Activity_Supp For Individual Animal Data,17423061,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,ALB,ug.mL-1,42000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,ALBUMIN,G/DL,UO_0000274,4.2
42016,See Activity_Supp For Individual Animal Data,17423062,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,ALP,U.L-1,431.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,ALKALINE PHOSPHATASE,u/L,,431.33
42017,See Activity_Supp For Individual Animal Data,17423063,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,AST,U.L-1,90.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,ASPARTATE AMINOTRANSFERASE,u/L,,90.67
42018,See Activity_Supp For Individual Animal Data,17423064,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,BUN,ug.mL-1,130.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,13.0
42019,See Activity_Supp For Individual Animal Data,17423065,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,2834994,=,15,1,=,CO2,nM,27670000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,CARBON DIOXIDE,MMOL/L,UO_0000065,27.67
42020,See Activity_Supp For Individual Animal Data,17423066,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,CHLORIDE,mEq.L-1,100.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,CHLORIDE,MEQ/L,,100.67
42021,See Activity_Supp For Individual Animal Data,17423067,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,CHOL,ug.mL-1,706.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,CHOLESTEROL,mg/dL,UO_0000274,70.67
42022,See Activity_Supp For Individual Animal Data,17423068,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,CK,U.L-1,342.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,CREATINE PHOSPHOKINASE,u/L,,342.0
42023,See Activity_Supp For Individual Animal Data,17423069,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,CREAT,ug.mL-1,2.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,CREATININE,mg/dL,UO_0000274,0.2
42024,See Activity_Supp For Individual Animal Data,17423070,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,GLUC,ug.mL-1,1493.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,GLUCOSE,mg/dL,UO_0000274,149.33
42025,See Activity_Supp For Individual Animal Data,17423071,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,LDH,U.L-1,413.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,LACTATE DEHYDROGENASE,u/L,,413.0
42026,See Activity_Supp For Individual Animal Data,17423072,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,LIPASE,U.L-1,10.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,LIPASE,u/L,,10.33
42027,See Activity_Supp For Individual Animal Data,17423073,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,PHOS,ug.mL-1,118.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,PHOSPHORUS,mg/dL,UO_0000274,11.8
42028,See Activity_Supp For Individual Animal Data,17423074,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,POTASSIUM,mEq.L-1,5.99,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,POTASSIUM,MEQ/L,,5.99
42029,See Activity_Supp For Individual Animal Data,17423075,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,SODIUM,mEq.L-1,145.2,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,SODIUM,MEQ/L,,145.2
42030,See Activity_Supp For Individual Animal Data,17423076,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,BILI,ug.mL-1,2.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.2
42031,See Activity_Supp For Individual Animal Data,17423077,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,PROT,ug.mL-1,59700.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,TOTAL PROTEIN,G/DL,UO_0000274,5.97
42032,See Activity_Supp For Individual Animal Data,17423078,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,URATE,ug.mL-1,14.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,URIC ACID,mg/dL,UO_0000274,1.43
42033,See Activity_Supp For Individual Animal Data,17423079,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,BASO,cells.uL-1,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,ABSOLUTE BASOPHIL,CELLS/uL,,0.0
42034,See Activity_Supp For Individual Animal Data,17423080,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,EOS,cells.uL-1,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,ABSOLUTE EOSINOPHIL,CELLS/uL,,0.0
42035,See Activity_Supp For Individual Animal Data,17423081,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,LYM,cells.uL-1,16055.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,ABSOLUTE LYMPHOCYTE,CELLS/uL,,16055.67
42036,See Activity_Supp For Individual Animal Data,17423082,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,MONO,cells.uL-1,361.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,ABSOLUTE MONOCYTE,CELLS/uL,,361.0
42037,See Activity_Supp For Individual Animal Data,17423083,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,NEUTSG,cells.uL-1,1450.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,ABSOLUTE SEGMENTED NEUTROPHIL,CELLS/uL,,1450.0
42038,See Activity_Supp For Individual Animal Data,17423084,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,BASOLE,%,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,BASOPHIL,%,UO_0000187,0.0
42039,See Activity_Supp For Individual Animal Data,17423085,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,EOSLE,%,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,EOSINOPHIL,%,UO_0000187,0.0
42040,See Activity_Supp For Individual Animal Data,17423086,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,RBC,cells.uL-1,5930000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,ERYTHROCYTE COUNT,x10E6/uL,,5.93
42041,See Activity_Supp For Individual Animal Data,17423087,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,HCT,%,37.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,HEMATOCRIT,%,UO_0000187,37.0
42042,See Activity_Supp For Individual Animal Data,17423088,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,HGB,ug.mL-1,146300.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,HEMOGLOBIN,G/DL,UO_0000274,14.63
42043,See Activity_Supp For Individual Animal Data,17423089,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,WBC,cells.uL-1,17870.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,LEUKOCYTE COUNT,x10E3/uL,,17.87
42044,See Activity_Supp For Individual Animal Data,17423090,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,LYMLE,%,90.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,LYMPHOCYTE,%,UO_0000187,90.0
42045,See Activity_Supp For Individual Animal Data,17423091,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,MCH,pg,24.73,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,24.73
42046,See Activity_Supp For Individual Animal Data,17423092,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,MCHC,ug.mL-1,395700.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,39.57
42047,See Activity_Supp For Individual Animal Data,17423093,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,MCV,fL,62.47,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,MEAN CORPUSCULAR VOLUME,FL,,62.47
42048,See Activity_Supp For Individual Animal Data,17423094,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,MONOLE,%,2.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,MONOCYTE,%,UO_0000187,2.0
42049,See Activity_Supp For Individual Animal Data,17423095,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,NEUTLE,%,8.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,NEUTROPHIL,%,UO_0000187,8.0
42050,See Activity_Supp For Individual Animal Data,17423096,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,RBCNUC,/100WBC,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,NUCLEATED RED BLOOD CELLS,/100WBC,,0.0
42051,See Activity_Supp For Individual Animal Data,17423097,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,PLAT,cells.uL-1,1096000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,PLATELET COUNT,x10E3/uL,,1096.0
42052,See Activity_Supp For Individual Animal Data,17423098,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,ALT,U.L-1,57.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,ALANINE AMINOTRANSFERASE,u/L,,57.0
42053,See Activity_Supp For Individual Animal Data,17423099,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,ALB,ug.mL-1,40700.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,ALBUMIN,G/DL,UO_0000274,4.07
42054,See Activity_Supp For Individual Animal Data,17423100,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,ALP,U.L-1,327.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,ALKALINE PHOSPHATASE,u/L,,327.0
42055,See Activity_Supp For Individual Animal Data,17423101,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,AST,U.L-1,64.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,ASPARTATE AMINOTRANSFERASE,u/L,,64.33
42056,See Activity_Supp For Individual Animal Data,17423102,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,BUN,ug.mL-1,110.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,11.0
42057,See Activity_Supp For Individual Animal Data,17423103,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,2834994,=,15,1,=,CO2,nM,24330000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,CARBON DIOXIDE,MMOL/L,UO_0000065,24.33
42058,See Activity_Supp For Individual Animal Data,17423104,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,CHLORIDE,mEq.L-1,103.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,CHLORIDE,MEQ/L,,103.67
42059,See Activity_Supp For Individual Animal Data,17423105,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,CHOL,ug.mL-1,370.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,CHOLESTEROL,mg/dL,UO_0000274,37.0
42060,See Activity_Supp For Individual Animal Data,17423106,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,CK,U.L-1,603.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,CREATINE PHOSPHOKINASE,u/L,,603.67
42061,See Activity_Supp For Individual Animal Data,17423107,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,CREAT,ug.mL-1,2.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,CREATININE,mg/dL,UO_0000274,0.29
42062,See Activity_Supp For Individual Animal Data,17423108,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,GLUC,ug.mL-1,3683.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,GLUCOSE,mg/dL,UO_0000274,368.33
42063,See Activity_Supp For Individual Animal Data,17423109,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,LDH,U.L-1,191.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,LACTATE DEHYDROGENASE,u/L,,191.67
42064,See Activity_Supp For Individual Animal Data,17423110,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,LIPASE,U.L-1,8.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,LIPASE,u/L,,8.67
42065,See Activity_Supp For Individual Animal Data,17423111,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,PHOS,ug.mL-1,125.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,PHOSPHORUS,mg/dL,UO_0000274,12.53
42066,See Activity_Supp For Individual Animal Data,17423112,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,POTASSIUM,mEq.L-1,6.44,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,POTASSIUM,MEQ/L,,6.44
42067,See Activity_Supp For Individual Animal Data,17423113,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,SODIUM,mEq.L-1,143.43,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,SODIUM,MEQ/L,,143.43
42068,See Activity_Supp For Individual Animal Data,17423114,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,BILI,ug.mL-1,1.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.13
42069,See Activity_Supp For Individual Animal Data,17423115,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,PROT,ug.mL-1,56000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,TOTAL PROTEIN,G/DL,UO_0000274,5.6
42070,See Activity_Supp For Individual Animal Data,17423116,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,URATE,ug.mL-1,21.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,URIC ACID,mg/dL,UO_0000274,2.13
42071,See Activity_Supp For Individual Animal Data,17423117,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,BASO,cells.uL-1,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,ABSOLUTE BASOPHIL,CELLS/uL,,0.0
42072,See Activity_Supp For Individual Animal Data,17423118,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,EOS,cells.uL-1,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,ABSOLUTE EOSINOPHIL,CELLS/uL,,0.0
42073,See Activity_Supp For Individual Animal Data,17423119,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,LYM,cells.uL-1,12067.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,ABSOLUTE LYMPHOCYTE,CELLS/uL,,12067.33
42074,See Activity_Supp For Individual Animal Data,17423120,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,MONO,cells.uL-1,215.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,ABSOLUTE MONOCYTE,CELLS/uL,,215.33
42075,See Activity_Supp For Individual Animal Data,17423121,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,NEUTSG,cells.uL-1,450.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,ABSOLUTE SEGMENTED NEUTROPHIL,CELLS/uL,,450.67
42076,See Activity_Supp For Individual Animal Data,17423122,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,BASOLE,%,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,BASOPHIL,%,UO_0000187,0.0
42077,See Activity_Supp For Individual Animal Data,17423123,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,EOSLE,%,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,EOSINOPHIL,%,UO_0000187,0.0
42078,See Activity_Supp For Individual Animal Data,17423124,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,RBC,cells.uL-1,6180000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,ERYTHROCYTE COUNT,x10E6/uL,,6.18
42079,See Activity_Supp For Individual Animal Data,17423125,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,HCT,%,38.03,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,HEMATOCRIT,%,UO_0000187,38.03
42080,See Activity_Supp For Individual Animal Data,17423126,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,HGB,ug.mL-1,151000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,HEMOGLOBIN,G/DL,UO_0000274,15.1
42081,See Activity_Supp For Individual Animal Data,17423127,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,WBC,cells.uL-1,12730.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,LEUKOCYTE COUNT,x10E3/uL,,12.73
42082,See Activity_Supp For Individual Animal Data,17423128,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,LYMLE,%,94.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,LYMPHOCYTE,%,UO_0000187,94.67
42083,See Activity_Supp For Individual Animal Data,17423129,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,MCH,pg,24.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,24.5
42084,See Activity_Supp For Individual Animal Data,17423130,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,MCHC,ug.mL-1,398300.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,39.83
42085,See Activity_Supp For Individual Animal Data,17423131,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,MCV,fL,61.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,MEAN CORPUSCULAR VOLUME,FL,,61.5
42086,See Activity_Supp For Individual Animal Data,17423132,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,MONOLE,%,1.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,MONOCYTE,%,UO_0000187,1.67
42087,See Activity_Supp For Individual Animal Data,17423133,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,NEUTLE,%,3.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,NEUTROPHIL,%,UO_0000187,3.67
42088,See Activity_Supp For Individual Animal Data,17423134,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,RBCNUC,/100WBC,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,NUCLEATED RED BLOOD CELLS,/100WBC,,0.0
42089,See Activity_Supp For Individual Animal Data,17423135,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,PLAT,cells.uL-1,1233670.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11976.0,PLATELET COUNT,x10E3/uL,,1233.67
42090,See Activity_Supp For Individual Animal Data,17423136,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,ALT,U.L-1,71.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,ALANINE AMINOTRANSFERASE,u/L,,71.0
42091,See Activity_Supp For Individual Animal Data,17423137,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,ALB,ug.mL-1,40000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,ALBUMIN,G/DL,UO_0000274,4.0
42092,See Activity_Supp For Individual Animal Data,17423138,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,ALP,U.L-1,300.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,ALKALINE PHOSPHATASE,u/L,,300.33
42093,See Activity_Supp For Individual Animal Data,17423139,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,AST,U.L-1,74.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,ASPARTATE AMINOTRANSFERASE,u/L,,74.33
42094,See Activity_Supp For Individual Animal Data,17423140,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,BUN,ug.mL-1,123.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,12.33
42095,See Activity_Supp For Individual Animal Data,17423141,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,2834994,=,15,1,=,CO2,nM,26670000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,CARBON DIOXIDE,MMOL/L,UO_0000065,26.67
42096,See Activity_Supp For Individual Animal Data,17423142,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,CHLORIDE,mEq.L-1,99.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,CHLORIDE,MEQ/L,,99.67
42097,See Activity_Supp For Individual Animal Data,17423143,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,CHOL,ug.mL-1,306.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,CHOLESTEROL,mg/dL,UO_0000274,30.67
42098,See Activity_Supp For Individual Animal Data,17423144,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,CK,U.L-1,501.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,CREATINE PHOSPHOKINASE,u/L,,501.33
42099,See Activity_Supp For Individual Animal Data,17423145,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,CREAT,ug.mL-1,2.9,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,CREATININE,mg/dL,UO_0000274,0.29
42100,See Activity_Supp For Individual Animal Data,17423146,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,GLUC,ug.mL-1,3383.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,GLUCOSE,mg/dL,UO_0000274,338.33
42101,See Activity_Supp For Individual Animal Data,17423147,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,LDH,U.L-1,199.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,LACTATE DEHYDROGENASE,u/L,,199.0
42102,See Activity_Supp For Individual Animal Data,17423148,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,LIPASE,U.L-1,8.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,LIPASE,u/L,,8.67
42103,See Activity_Supp For Individual Animal Data,17423149,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,PHOS,ug.mL-1,115.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,PHOSPHORUS,mg/dL,UO_0000274,11.53
42104,See Activity_Supp For Individual Animal Data,17423150,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,POTASSIUM,mEq.L-1,6.37,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,POTASSIUM,MEQ/L,,6.37
42105,See Activity_Supp For Individual Animal Data,17423151,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,SODIUM,mEq.L-1,141.3,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,SODIUM,MEQ/L,,141.3
42106,See Activity_Supp For Individual Animal Data,17423152,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,BILI,ug.mL-1,2.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,TOTAL BILIRUBIN,mg/dL,UO_0000274,0.2
42107,See Activity_Supp For Individual Animal Data,17423153,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,PROT,ug.mL-1,55300.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,TOTAL PROTEIN,G/DL,UO_0000274,5.53
42108,See Activity_Supp For Individual Animal Data,17423154,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,URATE,ug.mL-1,20.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,URIC ACID,mg/dL,UO_0000274,2.07
42109,See Activity_Supp For Individual Animal Data,17423155,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,BASO,cells.uL-1,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,ABSOLUTE BASOPHIL,CELLS/uL,,0.0
42110,See Activity_Supp For Individual Animal Data,17423156,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,EOS,cells.uL-1,57.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,ABSOLUTE EOSINOPHIL,CELLS/uL,,57.33
42111,See Activity_Supp For Individual Animal Data,17423157,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,LYM,cells.uL-1,15898.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,ABSOLUTE LYMPHOCYTE,CELLS/uL,,15898.0
42112,See Activity_Supp For Individual Animal Data,17423158,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,MONO,cells.uL-1,55.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,ABSOLUTE MONOCYTE,CELLS/uL,,55.0
42113,See Activity_Supp For Individual Animal Data,17423159,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,NEUTSG,cells.uL-1,1089.67,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,ABSOLUTE SEGMENTED NEUTROPHIL,CELLS/uL,,1089.67
42114,See Activity_Supp For Individual Animal Data,17423160,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,BASOLE,%,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,BASOPHIL,%,UO_0000187,0.0
42115,See Activity_Supp For Individual Animal Data,17423161,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,EOSLE,%,0.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,EOSINOPHIL,%,UO_0000187,0.33
42116,See Activity_Supp For Individual Animal Data,17423162,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,RBC,cells.uL-1,6680000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,ERYTHROCYTE COUNT,x10E6/uL,,6.68
42117,See Activity_Supp For Individual Animal Data,17423163,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,HCT,%,41.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,HEMATOCRIT,%,UO_0000187,41.6
42118,See Activity_Supp For Individual Animal Data,17423164,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,HGB,ug.mL-1,165000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,HEMOGLOBIN,G/DL,UO_0000274,16.5
42119,See Activity_Supp For Individual Animal Data,17423165,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,WBC,cells.uL-1,17100.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,LEUKOCYTE COUNT,x10E3/uL,,17.1
42120,See Activity_Supp For Individual Animal Data,17423166,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,LYMLE,%,93.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,LYMPHOCYTE,%,UO_0000187,93.0
42121,See Activity_Supp For Individual Animal Data,17423167,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,MCH,pg,24.7,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,MEAN CORPUSCULAR HEMOGLOBIN,PG,UO_0000025,24.7
42122,See Activity_Supp For Individual Animal Data,17423168,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834994,=,15,1,=,MCHC,ug.mL-1,396700.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION,G/DL,UO_0000274,39.67
42123,See Activity_Supp For Individual Animal Data,17423169,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,MCV,fL,62.27,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,MEAN CORPUSCULAR VOLUME,FL,,62.27
42124,See Activity_Supp For Individual Animal Data,17423170,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,MONOLE,%,0.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,MONOCYTE,%,UO_0000187,0.33
42125,See Activity_Supp For Individual Animal Data,17423171,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,2834994,=,15,1,=,NEUTLE,%,6.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,NEUTROPHIL,%,UO_0000187,6.33
42126,See Activity_Supp For Individual Animal Data,17423172,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,RBCNUC,/100WBC,0.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,NUCLEATED RED BLOOD CELLS,/100WBC,,0.0
42127,See Activity_Supp For Individual Animal Data,17423173,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,=,15,1,=,PLAT,cells.uL-1,1161000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,PLATELET COUNT,x10E3/uL,,1161.0
42128,See Activity_Supp For Individual Animal Data,17561513,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42129,See Activity_Supp For Individual Animal Data,17561514,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42130,See Activity_Supp For Individual Animal Data,17561515,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42131,See Activity_Supp For Individual Animal Data,17561516,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42132,See Activity_Supp For Individual Animal Data,17561517,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42133,See Activity_Supp For Individual Animal Data,17561518,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42134,See Activity_Supp For Individual Animal Data,17561519,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42135,See Activity_Supp For Individual Animal Data,17561520,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42136,See Activity_Supp For Individual Animal Data,17561521,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42137,See Activity_Supp For Individual Animal Data,17561522,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42138,See Activity_Supp For Individual Animal Data,17561523,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42139,See Activity_Supp For Individual Animal Data,17561524,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42140,See Activity_Supp For Individual Animal Data,17561525,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42141,See Activity_Supp For Individual Animal Data,17561526,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42142,See Activity_Supp For Individual Animal Data,17561527,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42143,See Activity_Supp For Individual Animal Data,17561528,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42144,See Activity_Supp For Individual Animal Data,17561529,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42145,See Activity_Supp For Individual Animal Data,17561530,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42146,See Activity_Supp For Individual Animal Data,17561531,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42147,See Activity_Supp For Individual Animal Data,17561532,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42148,See Activity_Supp For Individual Animal Data,17561533,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42149,See Activity_Supp For Individual Animal Data,17561534,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42150,See Activity_Supp For Individual Animal Data,17561535,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42151,See Activity_Supp For Individual Animal Data,17561536,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42152,See Activity_Supp For Individual Animal Data,17561537,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42153,See Activity_Supp For Individual Animal Data,17561538,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42154,See Activity_Supp For Individual Animal Data,17561539,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42155,See Activity_Supp For Individual Animal Data,17561540,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42156,See Activity_Supp For Individual Animal Data,17561541,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42157,See Activity_Supp For Individual Animal Data,17561542,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42158,See Activity_Supp For Individual Animal Data,17561543,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42159,See Activity_Supp For Individual Animal Data,17561544,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42160,See Activity_Supp For Individual Animal Data,17561545,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42161,See Activity_Supp For Individual Animal Data,17561546,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42162,See Activity_Supp For Individual Animal Data,17561547,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42163,See Activity_Supp For Individual Animal Data,17561548,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42164,See Activity_Supp For Individual Animal Data,17561549,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42165,See Activity_Supp For Individual Animal Data,17561550,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42166,See Activity_Supp For Individual Animal Data,17561551,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42167,See Activity_Supp For Individual Animal Data,17561552,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42168,See Activity_Supp For Individual Animal Data,17561553,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42169,See Activity_Supp For Individual Animal Data,17561554,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42170,See Activity_Supp For Individual Animal Data,17561555,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42171,See Activity_Supp For Individual Animal Data,17561556,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42172,See Activity_Supp For Individual Animal Data,17561557,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42173,See Activity_Supp For Individual Animal Data,17561558,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42174,See Activity_Supp For Individual Animal Data,17561559,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42175,See Activity_Supp For Individual Animal Data,17561560,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42176,See Activity_Supp For Individual Animal Data,17561561,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42177,See Activity_Supp For Individual Animal Data,17561562,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42178,See Activity_Supp For Individual Animal Data,17561563,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42179,See Activity_Supp For Individual Animal Data,17561564,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42180,See Activity_Supp For Individual Animal Data,17561565,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42181,See Activity_Supp For Individual Animal Data,17561566,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42182,See Activity_Supp For Individual Animal Data,17561567,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42183,See Activity_Supp For Individual Animal Data,17561568,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42184,See Activity_Supp For Individual Animal Data,17561569,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42185,See Activity_Supp For Individual Animal Data,17561570,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42186,See Activity_Supp For Individual Animal Data,17561571,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42187,See Activity_Supp For Individual Animal Data,17561572,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42188,See Activity_Supp For Individual Animal Data,17561573,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42189,See Activity_Supp For Individual Animal Data,17561574,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42190,See Activity_Supp For Individual Animal Data,17561575,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42191,See Activity_Supp For Individual Animal Data,17561576,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42192,See Activity_Supp For Individual Animal Data,17561577,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42193,See Activity_Supp For Individual Animal Data,17561578,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42194,See Activity_Supp For Individual Animal Data,17561579,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42195,See Activity_Supp For Individual Animal Data,17561580,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42196,See Activity_Supp For Individual Animal Data,17561581,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42197,See Activity_Supp For Individual Animal Data,17561582,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42198,See Activity_Supp For Individual Animal Data,17561583,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42199,See Activity_Supp For Individual Animal Data,17561584,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42200,See Activity_Supp For Individual Animal Data,17561585,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42201,See Activity_Supp For Individual Animal Data,17561586,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42202,See Activity_Supp For Individual Animal Data,17561587,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42203,See Activity_Supp For Individual Animal Data,17561588,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42204,See Activity_Supp For Individual Animal Data,17561589,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42205,See Activity_Supp For Individual Animal Data,17561590,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42206,See Activity_Supp For Individual Animal Data,17561591,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42207,See Activity_Supp For Individual Animal Data,17561592,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42208,See Activity_Supp For Individual Animal Data,17561593,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42209,See Activity_Supp For Individual Animal Data,17561594,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42210,See Activity_Supp For Individual Animal Data,17561595,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42211,See Activity_Supp For Individual Animal Data,17561596,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11975.0,Tissue Severity Score,,,
42212,See Activity_Supp For Individual Animal Data,17561597,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42213,See Activity_Supp For Individual Animal Data,17561598,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42214,See Activity_Supp For Individual Animal Data,17561599,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42215,See Activity_Supp For Individual Animal Data,17561600,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42216,See Activity_Supp For Individual Animal Data,17561601,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42217,See Activity_Supp For Individual Animal Data,17561602,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42218,See Activity_Supp For Individual Animal Data,17561603,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42219,See Activity_Supp For Individual Animal Data,17561604,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42220,See Activity_Supp For Individual Animal Data,17561605,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42221,See Activity_Supp For Individual Animal Data,17561606,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42222,See Activity_Supp For Individual Animal Data,17561607,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42223,See Activity_Supp For Individual Animal Data,17561608,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42224,See Activity_Supp For Individual Animal Data,17561609,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42225,See Activity_Supp For Individual Animal Data,17561610,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42226,See Activity_Supp For Individual Animal Data,17561611,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42227,See Activity_Supp For Individual Animal Data,17561612,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42228,See Activity_Supp For Individual Animal Data,17561613,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42229,See Activity_Supp For Individual Animal Data,17561614,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42230,See Activity_Supp For Individual Animal Data,17561615,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42231,See Activity_Supp For Individual Animal Data,17561616,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42232,See Activity_Supp For Individual Animal Data,17561617,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42233,See Activity_Supp For Individual Animal Data,17561618,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42234,See Activity_Supp For Individual Animal Data,17561619,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42235,See Activity_Supp For Individual Animal Data,17561620,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42236,See Activity_Supp For Individual Animal Data,17561621,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42237,See Activity_Supp For Individual Animal Data,17561622,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42238,See Activity_Supp For Individual Animal Data,17561623,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42239,See Activity_Supp For Individual Animal Data,17561624,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42240,See Activity_Supp For Individual Animal Data,17561625,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42241,See Activity_Supp For Individual Animal Data,17561626,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42242,See Activity_Supp For Individual Animal Data,17561627,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42243,See Activity_Supp For Individual Animal Data,17561628,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42244,See Activity_Supp For Individual Animal Data,17561629,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42245,See Activity_Supp For Individual Animal Data,17561630,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42246,See Activity_Supp For Individual Animal Data,17561631,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42247,See Activity_Supp For Individual Animal Data,17561632,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42248,See Activity_Supp For Individual Animal Data,17561633,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42249,See Activity_Supp For Individual Animal Data,17561634,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42250,See Activity_Supp For Individual Animal Data,17561635,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42251,See Activity_Supp For Individual Animal Data,17561636,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42252,See Activity_Supp For Individual Animal Data,17561637,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42253,See Activity_Supp For Individual Animal Data,17561638,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42254,See Activity_Supp For Individual Animal Data,17561639,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42255,See Activity_Supp For Individual Animal Data,17561640,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42256,See Activity_Supp For Individual Animal Data,17561641,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42257,See Activity_Supp For Individual Animal Data,17561642,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42258,See Activity_Supp For Individual Animal Data,17561643,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42259,See Activity_Supp For Individual Animal Data,17561644,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42260,See Activity_Supp For Individual Animal Data,17561645,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42261,See Activity_Supp For Individual Animal Data,17561646,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42262,See Activity_Supp For Individual Animal Data,17561647,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42263,See Activity_Supp For Individual Animal Data,17561648,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42264,See Activity_Supp For Individual Animal Data,17561649,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42265,See Activity_Supp For Individual Animal Data,17561650,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42266,See Activity_Supp For Individual Animal Data,17561651,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42267,See Activity_Supp For Individual Animal Data,17561652,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42268,See Activity_Supp For Individual Animal Data,17561653,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42269,See Activity_Supp For Individual Animal Data,17561654,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42270,See Activity_Supp For Individual Animal Data,17561655,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42271,See Activity_Supp For Individual Animal Data,17561656,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42272,See Activity_Supp For Individual Animal Data,17561657,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42273,See Activity_Supp For Individual Animal Data,17561658,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42274,See Activity_Supp For Individual Animal Data,17561659,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42275,See Activity_Supp For Individual Animal Data,17561660,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42276,See Activity_Supp For Individual Animal Data,17561661,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42277,See Activity_Supp For Individual Animal Data,17561662,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42278,See Activity_Supp For Individual Animal Data,17561663,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42279,See Activity_Supp For Individual Animal Data,17561664,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42280,See Activity_Supp For Individual Animal Data,17561665,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42281,See Activity_Supp For Individual Animal Data,17561666,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42282,See Activity_Supp For Individual Animal Data,17561667,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42283,See Activity_Supp For Individual Animal Data,17561668,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42284,See Activity_Supp For Individual Animal Data,17561669,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42285,See Activity_Supp For Individual Animal Data,17561670,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42286,See Activity_Supp For Individual Animal Data,17561671,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42287,See Activity_Supp For Individual Animal Data,17561672,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42288,See Activity_Supp For Individual Animal Data,17561673,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42289,See Activity_Supp For Individual Animal Data,17561674,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42290,See Activity_Supp For Individual Animal Data,17561675,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42291,See Activity_Supp For Individual Animal Data,17561676,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42292,See Activity_Supp For Individual Animal Data,17561677,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42293,See Activity_Supp For Individual Animal Data,17561678,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42294,See Activity_Supp For Individual Animal Data,17561679,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42295,See Activity_Supp For Individual Animal Data,17561680,CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3885881,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2834994,,15,0,,Tissue Severity Score,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,11977.0,Tissue Severity Score,,,
42296,,17969301,CHEMBL3995599,Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3994613,Eur J Med Chem,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2977530,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
42297,,18061794,CHEMBL4013417,Ratio of MIC for Staphylococcus aureus ATCC 29213 after 15 passages to MIC for Staphylococcus aureus ATCC 29213,F,BAO_0000193,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4011638,J Med Chem,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,2993624,=,1,0,=,Ratio,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,64.0
42298,,18245701,CHEMBL4053351,Ratio of MIC for Staphylococcus aureus ATCC 29213 after and before 15 serial passages,F,BAO_0000193,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4052597,J Med Chem,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,3027671,=,1,0,=,Ratio,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,64.0
42299,,18247998,CHEMBL4053774,Antitubercular activity against Mycobacterium tuberculosis H37Rv,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4052616,Eur J Med Chem,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3028278,=,1,1,=,MIC,ug.mL-1,3.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,3.12
42300,,18267865,CHEMBL4057937,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by two fold dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4052775,Bioorg Med Chem Lett,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3031969,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.78
42301,,18267880,CHEMBL4057938,Antimycobacterial activity against isoniazid/rifampicin/ethambutol-resistant Mycobacterium tuberculosis 09710 by two fold dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4052775,Bioorg Med Chem Lett,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3031969,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
42302,,18267895,CHEMBL4057939,Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 72 hrs by MTT assay,A,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4052775,Bioorg Med Chem Lett,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3031969,=,1,1,=,CC50,ug.mL-1,125.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,CC50,ug ml-1,UO_0000274,125.0
42303,,18267903,CHEMBL4057943,"Selectivity index, ratio of CC50 for African green monkey Vero cells to MIC for Mycobacterium tuberculosis H37Rv ATCC 27294",T,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4052775,Bioorg Med Chem Lett,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,3031969,=,1,0,=,Selectivity Index,,160.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,160.0
42304,,18280020,CHEMBL4119628,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 3 to 7 days by rapid direct susceptibility test,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4118076,Eur J Med Chem,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3034076,=,1,1,=,MIC90,ug.mL-1,0.78,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,ug ml-1,UO_0000274,0.78
42305,,18280029,CHEMBL4119629,Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis after 3 to 7 days by rapid direct susceptibility test,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4118076,Eur J Med Chem,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3034076,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,ug ml-1,UO_0000274,1.0
42306,,18280050,CHEMBL4119630,Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 72 hrs by MTT assay,A,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4118076,Eur J Med Chem,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3034076,=,1,1,=,CC50,ug.mL-1,125.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,CC50,ug ml-1,UO_0000274,125.0
42307,,18537489,CHEMBL4196757,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
42308,,18537491,CHEMBL4196758,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
42309,,18537493,CHEMBL4196759,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
42310,,18537495,CHEMBL4196760,Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42311,,18537497,CHEMBL4196761,Antibacterial activity against methicillin-sensitive Staphylococcus aureus by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42312,,18537499,CHEMBL4196762,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42313,,18537501,CHEMBL4196756,Antibacterial activity against Escherichia coli ATCC 700603 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
42314,,18537503,CHEMBL4196763,Antibacterial activity against Klebsiella pneumoniae ATCC 25922 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
42315,,18537504,CHEMBL4196764,Antibacterial activity against Bacillus subtilis NCDC 71 after overnight incubation by single disc method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,5.0
42316,,18537508,CHEMBL4196765,Antibacterial activity against Escherichia coli NCDC 134 after overnight incubation by single disc method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,5.0
42317,,18537512,CHEMBL4196766,Antibacterial activity against Pseudomonas aeruginosa NCDC105 after overnight incubation by single disc method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,5.0
42318,,18537516,CHEMBL4196767,Antibacterial activity against Paenibacillus polymyxa NCDC 64 after overnight incubation by single disc method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL4296587,Paenibacillus polymyxa,Paenibacillus polymyxa,1406.0,,MIC,ug ml-1,UO_0000274,5.0
42319,,18537520,CHEMBL4196768,Antibacterial activity against Staphylococcus aureus NCDC 110 after overnight incubation by single disc method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4196012,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3077735,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,5.0
42320,,18581976,CHEMBL4222876,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate CCARM 3167 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085801,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
42321,,18582003,CHEMBL4222875,Antibacterial activity against quinolone-resistant Staphylococcus aureus isolate CCARM 3505 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085801,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42322,,18582036,CHEMBL4222874,Antibacterial activity against Staphylococcus aureus 4220 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085801,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
42323,,18582051,CHEMBL4222877,Antibacterial activity against Streptococcus mutans 3289 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085801,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,MIC,ug ml-1,UO_0000274,0.5
42324,,18582078,CHEMBL4222878,Antifungal activity against Candida albicans 7535 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085801,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,2.0
42325,,18582105,CHEMBL4222879,Antibacterial activity against Escherichia coli 1924 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085801,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
42326,,18582132,CHEMBL4222880,Antibacterial activity against Pseudomonas aeruginosa 2742 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4219177,Bioorg Med Chem Lett,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085801,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
42327,,18653870,CHEMBL4230262,Antibacterial activity against multidrug resistant Mycobacterium tuberculosis ATTC 27294 by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4229334,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3098185,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.1
42328,,18690727,CHEMBL4253102,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4251589,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104377,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.02
42329,,18829097,CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4303101,,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,3135595,=,52,1,=,Inhibition,%,-3.99,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,Inhibition,%,UO_0000187,-3.99
42330,,18853858,CHEMBL4306932,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147109,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
42331,,18853859,CHEMBL4306933,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis by two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147109,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
42332,,18853860,CHEMBL4306934,Antibacterial activity against methicillin-resistant Staphylococcus aureus by two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147109,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42333,,18853861,CHEMBL4306935,Antibacterial activity against methicillin-sensitive Staphylococcus aureus by two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4304773,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147109,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42334,,18911519,CHEMBL4321113,Antibacterial activity against Staphylococcus aureus RN4220 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154620,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
42335,,18911577,CHEMBL4321114,Antibacterial activity against Streptococcus mutans 3289 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154620,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,MIC,ug ml-1,UO_0000274,0.25
42336,,18911609,CHEMBL4321115,Antibacterial activity against Escherichia coli KCTC 1924 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154620,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
42337,Not Determined,18911641,CHEMBL4321116,Antifungal activity against Candida albicans 7535 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,3154620,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
42338,,18911673,CHEMBL4321117,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154620,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42339,,18911705,CHEMBL4321118,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154620,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42340,,18911737,CHEMBL4321119,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154620,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
42341,,18911769,CHEMBL4321120,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by microtiter ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154620,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
42342,,19027500,CHEMBL4348794,Antibacterial activity against Staphylococcus aureus RN4220 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174485,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
42343,,19027529,CHEMBL4348795,Antibacterial activity against Staphylococcus aureus KCTC209 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174485,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42344,,19027558,CHEMBL4348796,Antibacterial activity against Staphylococcus aureus KCTC503 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174485,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
42345,,19027587,CHEMBL4348797,Antibacterial activity against Streptococcus mutans KCTC3289 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174485,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,MIC,ug ml-1,UO_0000274,0.25
42346,,19027616,CHEMBL4348798,Antibacterial activity against Escherichia coli 1924 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174485,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
42347,,19027645,CHEMBL4348799,Antibacterial activity against Pseudomonas aeruginosa 2742 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174485,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
42348,,19027674,CHEMBL4348800,Antifungal activity against Candida albicans 7535 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174485,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,0.5
42349,,19027703,CHEMBL4348801,Antibacterial activity against Methicillin-resistant Staphylococcus aureus CCARM 3167 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174485,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42350,,19027733,CHEMBL4348802,Antibacterial activity against Methicillin-resistant Staphylococcus aureus CCARM 3506 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174485,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42351,,19027763,CHEMBL4348803,Antibacterial activity against Quinolone-resistant Staphylococcus aureus CCARM 3505 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174485,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
42352,,19027793,CHEMBL4348804,Antibacterial activity against Quinolone-resistant Staphylococcus aureus CCARM 3519 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4346701,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174485,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
42353,,19051586,CHEMBL4354972,Antibacterial activity against Pseudomonas aeruginosa by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178405,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,mg/L,UO_0000274,4.0
42354,,19051600,CHEMBL4354971,Antibacterial activity against Escherichia coli by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178405,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,mg/L,UO_0000274,0.06
42355,,19051610,CHEMBL4354973,Antibacterial activity against Klebsiella by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178405,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL612535,Klebsiella,Klebsiella,570.0,,MIC90,mg/L,UO_0000274,0.25
42356,,19051624,CHEMBL4354974,Antibacterial activity against Bacteroides fragilis by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178405,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC90,mg/L,UO_0000274,1.0
42357,,19051638,CHEMBL4354975,Antibacterial activity against Haemophilus influenzae with horse blood by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178405,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,mg/L,UO_0000274,0.03
42358,,19051652,CHEMBL4354976,Antibacterial activity against Staphylococcus aureus by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178405,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,mg/L,UO_0000274,0.25
42359,,19051666,CHEMBL4354977,Antibacterial activity against Streptococcus pneumoniae by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178405,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,mg/L,UO_0000274,0.25
42360,,19051680,CHEMBL4354978,Antibacterial activity against Streptococcus pyogenes by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178405,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,mg/L,UO_0000274,0.25
42361,,19051694,CHEMBL4354979,Antibacterial activity against Enterococcus by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178405,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC90,mg/L,UO_0000274,1.0
42362,,19051708,CHEMBL4354980,Antibacterial activity against Clostridium perfringens by agar diffusion method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178405,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC90,mg/L,UO_0000274,0.5
42363,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,19051737,CHEMBL4354995,"Cmax in human at 0.4 g, po",A,BAO_0002119,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3178405,=,1,1,=,Cmax,nM,10122.54,CHEMBL612558,,ADMET,,,Cmax,mg/L,UO_0000065,3.8
42364,,19051742,CHEMBL4354996,"AUC in human at 0.4 g, po",A,BAO_0002120,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,3178405,=,1,1,=,AUC,ng.hr.mL-1,33000.0,CHEMBL612558,,ADMET,,,AUC,mg.hr/L,,33.0
42365,,19051747,CHEMBL4354997,"Half life in human at 0.4 g, po",A,BAO_0002115,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Hour,3178405,=,1,1,=,T1/2,hr,12.0,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,12.0
42366,,19099298,CHEMBL4368178,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 7 days by rapid direct susceptibility test,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4364323,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186254,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.5
42367,,19099316,CHEMBL4368179,Cytotoxicity against African green monkey Vero cells incubated for 72 hrs by MTT assay,A,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4364323,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186254,=,1,1,=,CC50,ug.mL-1,64.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,CC50,ug ml-1,UO_0000274,64.0
42368,,19099334,CHEMBL4368180,"Selectivity index, ratio of CC50 for African green monkey Vero cells to MIC for Mycobacterium tuberculosis H37Rv",T,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4364323,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,3186254,=,1,0,=,Selectivity Index,,128.0,CHEMBL612545,,Unchecked,,,Selectivity Index,,,128.0
42369,,19099342,CHEMBL4368181,Inhibition of Mycobacterium tuberculosis DNA gyrase,B,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4364323,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186254,=,1,1,=,IC50,ug.mL-1,5.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,ug ml-1,UO_0000274,5.0
42370,,19099348,CHEMBL4368182,Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis incubated for 7 days by rapid direct susceptibility test,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4364323,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186254,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
42371,,19099356,CHEMBL4368183,Antimycobacterial activity against multidrug (isoniazid and rifampicin) resistant Mycobacterium tuberculosis 1 incubated for 7 days by rapid direct susceptibility test,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4364323,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186254,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.25
42372,,19099364,CHEMBL4368184,Antimycobacterial activity against multidrug (isoniazid and rifampicin) resistant Mycobacterium tuberculosis 2 incubated for 7 days by rapid direct susceptibility test,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4364323,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186254,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.5
42373,,19166249,CHEMBL4384164,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 3 to 7 days by rapid direct susceptibility test,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198692,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.5
42374,,19166276,CHEMBL4384166,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis after 3 to 7 days by rapid direct susceptibility test,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4382234,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198692,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
42375,,19237693,CHEMBL4399097,Antibacterial activity against Staphylococcus aureus ATCC 6538 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
42376,,19237716,CHEMBL4399098,Bactericidal activity against Staphylococcus aureus ATCC 6538 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.25
42377,,19237740,CHEMBL4399099,Antibacterial activity against methicillin resistant Staphylococcus aureus N315 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
42378,,19237763,CHEMBL4399100,Bactericidal activity against methicillin resistant Staphylococcus aureus N315 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.125
42379,,19237787,CHEMBL4399101,Antibacterial activity against Staphylococcus epidermidis ATCC 14990 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
42380,,19237810,CHEMBL4399102,Bactericidal activity against Staphylococcus epidermidis ATCC 14990 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,0.25
42381,,19237834,CHEMBL4399103,Antibacterial activity against Enterococcus hirae ATCC 1052 cultured in BHI medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MIC,ug ml-1,UO_0000274,8.0
42382,,19237846,CHEMBL4399104,Bactericidal activity against Enterococcus hirae ATCC 1052 cultured in BHI medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,16.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MBC,ug ml-1,UO_0000274,16.0
42383,,19237869,CHEMBL4399105,Antibacterial activity against Bacillus subtilis ATCC 6633 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC,ug ml-1,UO_0000274,0.032
42384,,19237892,CHEMBL4399106,Bactericidal activity against Bacillus subtilis ATCC 6633 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,0.063,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MBC,ug ml-1,UO_0000274,0.063
42385,,19237916,CHEMBL4399107,Antibacterial activity against Escherichia coli ATCC 8739 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
42386,,19237939,CHEMBL4399108,Bactericidal activity against Escherichia coli ATCC 8739 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.032
42387,,19237963,CHEMBL4399109,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
42388,,19237986,CHEMBL4399110,Bactericidal activity against Pseudomonas aeruginosa ATCC 9027 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,0.25
42389,,19238010,CHEMBL4399111,Antibacterial activity against Proteus vulgaris NCTC 4635 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.008
42390,,19238034,CHEMBL4399112,Bactericidal activity against Proteus vulgaris NCTC 4635 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,0.008,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MBC,ug ml-1,UO_0000274,0.008
42391,,19238058,CHEMBL4399113,Antibacterial activity against methicillin resistant Staphylococcus aureus 6347 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
42392,,19238081,CHEMBL4399114,Bactericidal activity against methicillin resistant Staphylococcus aureus 6347 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.125
42393,,19238105,CHEMBL4399115,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 13199 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.063
42394,,19238128,CHEMBL4399116,Bactericidal activity against methicillin resistant Staphylococcus epidermidis ATCC 13199 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,0.063,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,0.063
42395,,19238152,CHEMBL4399117,Antibacterial activity against Streptococcus pneumoniae cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42396,,19238166,CHEMBL4399118,Bactericidal activity against Streptococcus pneumoniae cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MBC,ug ml-1,UO_0000274,256.0
42397,,19238190,CHEMBL4399119,Antibacterial activity against Serratia marcescens ATCC 12795 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.25
42398,,19238213,CHEMBL4399120,Bactericidal activity against Serratia marcescens ATCC 12795 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211474,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MBC,ug ml-1,UO_0000274,0.5
42399,,19238371,CHEMBL4399138,"Resistance index, ratio of MIC for Proteus vulgaris NCTC 4635 measured after 5 dilution steps to MIC for Proteus vulgaris NCTC 4635 measured after 48 hrs incubation by microbroth dilution method",F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4396913,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,3211474,=,1,0,=,Ratio,,32.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,Ratio,,,32.0
42400,,19247102,CHEMBL4400925,Antibacterial activity against Streptococcus pyogenes CMCC 32067 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,>,1,1,>,MIC,nM,341330.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,umol/L,UO_0000065,341.33
42401,,19247143,CHEMBL4400924,Antibacterial activity against Staphylococcus aureus CMCC 25923 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,330.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,umol/L,UO_0000065,0.33
42402,,19247184,CHEMBL4400923,Antibacterial activity against Staphylococcus aureus CMCC(B) 26003 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,330.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,umol/L,UO_0000065,0.33
42403,,19247227,CHEMBL4400928,Antibacterial activity against Bacillus subtilis CMCC 63501 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,5330.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,umol/L,UO_0000065,5.33
42404,,19247271,CHEMBL4400927,Antibacterial activity against Enterococcus faecalis CMCC 29212 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,2670.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,umol/L,UO_0000065,2.67
42405,,19247312,CHEMBL4400926,Antibacterial activity against Streptococcus pneumoniae CMCC 31968 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,>,1,1,>,MIC,nM,341330.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,umol/L,UO_0000065,341.33
42406,,19247352,CHEMBL4400929,Antibacterial activity against Escherichia coli CMCC 25922 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,330.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,umol/L,UO_0000065,0.33
42407,,19247393,CHEMBL4400930,Antibacterial activity against Escherichia coli CMCC 44568 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,330.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,umol/L,UO_0000065,0.33
42408,,19247434,CHEMBL4400931,Antibacterial activity against Pseudomonas aeruginosa CMCC 27853 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,5330.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,umol/L,UO_0000065,5.33
42409,,19247475,CHEMBL4400932,Antibacterial activity against Pseudomonas aeruginosa CMCC 10104 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,5330.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,umol/L,UO_0000065,5.33
42410,,19247486,CHEMBL4400933,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,1330.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,umol/L,UO_0000065,1.33
42411,,19247497,CHEMBL4400934,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,670.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,umol/L,UO_0000065,0.67
42412,,19247508,CHEMBL4400935,Antibacterial activity against multidrug-resistant Escherichia coli ATCC BAA-196 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,1330.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,umol/L,UO_0000065,1.33
42413,,19247519,CHEMBL4400936,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa ATCC BAA-2111 measured after 24 hrs by ELISA,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4400518,Eur J Med Chem,2019.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3213106,=,1,1,=,MIC,nM,2660.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,umol/L,UO_0000065,2.66
42414,,19265107,CHEMBL4405023,"In vivo antibacterial activity against Staphylococcus aureus ATCC 29213 infected in C57BL/6 mouse assessed as reduction in bacterial burden by measuring log10 CFU/cornea at 0.3% administered topically as two times on day 1, four times on day 2 and two times on day 3 measured at 48 hrs post-final dose by 10 fold serial dilution method (Rvb = 6.5 +/- 0.7 log10CFU)",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4402583,J Med Chem,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,3217038,=,1,0,=,Activity,log10CFU,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,log10CFU,,2.5
42415,,19265117,CHEMBL4405029,Ratio of MIC for vancomycin-resistant Enterococcus faecalis 1010 to MIC for Mel-5-resistant vancomycin-resistant Enterococcus faecalis 1010 incubated for 24 hrs by broth microdilution method,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4402583,J Med Chem,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,3217038,=,1,0,=,Ratio,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Ratio,,,8.0
42416,,19265127,CHEMBL4405007,Antibacterial activity against Mel-5-resistant vancomycin-resistant Enterococcus faecalis 1010 assessed as reduction in bacterial growth measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4402583,J Med Chem,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3217038,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
42417,,19265128,CHEMBL4405033,Antibacterial activity against vancomycin-resistant Enterococcus faecalis 1010 assessed as reduction in bacterial growth measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4402583,J Med Chem,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3217038,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
42418,,19406515,CHEMBL4426537,Inhibition of wild type Staphylococcus aureus topoisomerase 4 assessed as compound concentration causing 50% induction of cleavage of covalently closed DNA substrate,B,BAO_0000187,BAO_0000223,protein complex format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3243527,=,1,1,=,CC50,nM,200.0,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,CC50,uM,UO_0000065,0.2
42419,,19406518,CHEMBL4426538,Inhibition of wild type Staphylococcus aureus gyrase assessed as compound concentration causing 50% induction of cleavage of covalently closed DNA substrate,B,BAO_0000187,BAO_0000223,protein complex format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3243527,=,1,1,=,CC50,nM,700.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,CC50,uM,UO_0000065,0.7
42420,,19406521,CHEMBL4426539,Inhibition of FQ-resistant Staphylococcus aureus topoisomerase 4 ParC S80F mutant assessed as compound concentration causing 50% induction of cleavage of covalently closed DNA substrate,B,BAO_0000187,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3243527,=,1,1,=,CC50,nM,13000.0,CHEMBL612545,,Unchecked,,,CC50,uM,UO_0000065,13.0
42421,,19406524,CHEMBL4426540,Inhibition of FQ-resistant Staphylococcus aureus GyrA S84L mutant assessed as compound concentration causing 50% induction of cleavage of covalently closed DNA substrate,B,BAO_0000187,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,1,http://www.openphacts.org/units/Nanomolar,3243527,=,1,1,=,CC50,nM,18000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,CC50,uM,UO_0000065,18.0
42422,,19406534,CHEMBL4426544,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing gyrA S84L mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243527,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
42423,,19406538,CHEMBL4426546,Antimicrobial activity against wild type Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243527,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42424,,19406544,CHEMBL4426549,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243527,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
42425,,19406550,CHEMBL4426551,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing gyrA S84L and parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243527,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
42426,,19406556,CHEMBL4426554,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243527,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42427,,19406562,CHEMBL4426557,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y and gyrA S84L mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243527,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
42428,,19406568,CHEMBL4426560,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y and parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243527,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
42429,,19406574,CHEMBL4426563,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y/gyrA S84L/parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4425125,J Med Chem,2016.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243527,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
42430,,19958249,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4495564,,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,3344667,=,52,1,=,Inhibition,%,22.31,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,22.31
42431,,19959426,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4495564,,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,3345844,=,52,1,=,Inhibition,%,8.909,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,8.90883488
42432,,20148379,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4495565,,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,3363716,=,52,1,=,Inhibition,%,0.15,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.15
42433,,20149542,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4495565,,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,3362539,=,52,1,=,Inhibition,%,0.09,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.09
42434,Median N= 2; Maxinhib 2.9 Pct,20163029,CHEMBL4296189,"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4513141,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3370035,>,40,1,>,MIC,nM,10000.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,uM,UO_0000065,10.0
42435,Median N= 2; Maxinhib 10.1 Pct,20163030,CHEMBL4296190,"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4513141,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3370035,>,40,1,>,MIC,nM,10000.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MIC,uM,UO_0000065,10.0
42436,Median N= 2,20163031,CHEMBL4296185,"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4513141,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3370035,<=,40,1,<=,MIC,nM,78.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.0781
42437,Median N= 2; Range 5 - 2.5  Um,20163032,CHEMBL4296186,"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4513141,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3370035,=,40,1,=,MIC,nM,2500.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,2.5
42438,Median N= 2,20163033,CHEMBL4296187,"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4513141,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3370035,=,40,1,=,MIC,nM,625.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.625
42439,Median N= 2; Range 2.5 - 1.25  Um,20163034,CHEMBL4296188,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4513141,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3370035,=,40,1,=,MIC,nM,1250.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,1.25
42440,Median N= 2,20163035,CHEMBL4296184,"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4513141,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3370035,=,40,1,=,MIC,nM,312.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.3125
42441,,20692067,CHEMBL4625799,Antimalarial activity against CQ-sensitive Plasmodium falciparum 3D7 assessed as inhibition of parasite growth,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4622966,ACS Med Chem Lett,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3485175,>,1,1,>,IC50,nM,10000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,10.0
42442,,20692068,CHEMBL4625800,Antimalarial activity against CQ-resistant Plasmodium falciparum NF54-R assessed as inhibition of parasite growth,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4622966,ACS Med Chem Lett,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3485175,>,1,1,>,IC50,nM,10000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,10.0
42443,,22074029,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4495565,,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,3362539,=,52,1,=,Inhibition,%,0.09,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.09
42444,,22075206,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4495565,,2020.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://qudt.org/vocab/unit#Percent,3363716,=,52,1,=,Inhibition,%,0.15,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.15
42445,No. Measurements = 1,22081788,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4651402,,2021.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3493800,>,57,1,>,IC50,nM,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,IC50,M,UO_0000065,2e-05
42446,No. Measurements = 1,22081789,CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL4651402,,2021.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3493800,<,57,1,>,IC50,nM,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,pIC50,,UO_0000065,4.7
42447,,24837161,CHEMBL5144782,Antibacterial activity against rifampicin resistant Staphylococcus aureus harboring RpoBH481Y mutant assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879310,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.063
42448,,24837196,CHEMBL5144783,Antibacterial activity against wild type Staphylococcus aureus assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879310,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.063
42449,,24837231,CHEMBL5144784,Antibacterial activity against ciprofloxacin resistant Staphylococcus aureus harboring ParCS80F and GyrAS84L double mutant assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879310,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42450,,24837266,CHEMBL5144785,Antibacterial activity against Staphylococcus aureus harboring RpoBH481Y/ParCS80F/GyrAS84L triple mutant assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879310,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42451,,24837301,CHEMBL5144786,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879310,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
42452,,24846093,CHEMBL5146740,"Antibacterial activity against beta-lactams, macrolide and fluoroquinolone resistant Streptococcus pneumoniae 718 infected in po dosed Swiss mouse septicemia model assessed as protective dose administered on 1 and 5 hrs post infection and measured on day 7",F,BAO_0000188,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,,3881073,>,1,0,>,EC50,mg kg-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,EC50,mg kg-1,UO_0000308,100.0
42453,,24959021,CHEMBL5215176,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in bacterial growth incubated for 72 hrs by two-fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5214886,Eur J Med Chem,2021.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3898743,=,1,1,=,MIC,nM,660.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.66
42454,,25029985,CHEMBL5241345,Antimicrobial activity against Methicillin sensitive Staphylococcus aureus assessed as bacterial growth inhibition incubated for 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5241058,Eur J Med Chem,2021.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918736,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42455,,25032680,CHEMBL5242331,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919830,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42456,,25032944,CHEMBL5242360,Antibacterial activity against methicillin susceptible Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919830,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42457,,25032946,CHEMBL5242361,Antibacterial activity against Streptococcus pneumoniae,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919830,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
42458,,25040072,CHEMBL5244529,Antimalarial activity against hepatic stage Plasmodium yoelii yoelii 265 BY for 48 hrs with media renew every 24 hrs,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922432,>,1,1,>,IC50,ug.mL-1,100.0,CHEMBL612328,Plasmodium yoelii yoelii,Plasmodium yoelii yoelii,73239.0,,IC50,ug ml-1,UO_0000274,100.0
42459,,25040096,CHEMBL5244530,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum NF54-R infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922432,=,1,1,=,IC50,ug.mL-1,10.9,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ug ml-1,UO_0000274,10.9
42460,,25040122,CHEMBL5244531,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922432,=,1,1,=,IC50,ug.mL-1,34.8,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ug ml-1,UO_0000274,34.8
42461,,25040703,CHEMBL5244788,Antimicrobial activity against methicillin-resistant Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922740,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
42462,,25040733,CHEMBL5244793,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs by Agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922740,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42463,,25040857,CHEMBL5244811,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922740,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42464,,25041221,CHEMBL5244874,Antibacterial activity against Escherichia coli NCDC 134 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922895,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,100.0
42465,,25041270,CHEMBL5244878,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 18 to 20 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922895,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
42466,,25041308,CHEMBL5244890,Antibacterial activity against Escherichia coli H560 assessed as bacterial growth inhibition,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922895,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
42467,,25041319,CHEMBL5244893,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922895,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,4.0
42468,,25103810,CHEMBL5262789,Antimycobacterial activity against Mycobacterium tuberculosis Rv0005 harbouring gyrB gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5260811,Eur J Med Chem,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936461,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
42469,,25103815,CHEMBL5262790,Antimycobacterial activity against Mycobacterium tuberculosis Rv0006 harbouring gyrA gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5260811,Eur J Med Chem,2017.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936461,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
42470,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120119,CHEMBL5291755,Compound was evaluated for inhibition of rat Cacna1c in an in vitro assay with cellular components measured by membrane filtration,F,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5291721,Nat Commun,2023.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3940425,>,1,1,>,AC50,nM,10000.0,CHEMBL3762,Rattus norvegicus,Voltage-gated L-type calcium channel alpha-1C subunit,10116.0,,AC50,uM,UO_0000065,10.0
42471,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25121241,CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5291721,Nat Commun,2023.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3940425,>,1,1,>,AC50,nM,10000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,AC50,uM,UO_0000065,10.0
42472,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25128635,CHEMBL5291798,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,B,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5291721,Nat Commun,2023.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3940425,>,1,1,>,AC50,nM,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,AC50,uM,UO_0000065,10.0
42473,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25131265,CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5291721,Nat Commun,2023.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3940425,>,1,1,>,AC50,nM,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,AC50,uM,UO_0000065,10.0
42474,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25175069,CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,BAO_0000186,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5291721,Nat Commun,2023.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3940425,>,1,1,>,AC50,nM,10000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,AC50,uM,UO_0000065,10.0
42475,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187810,CHEMBL5291748,Binding affinity towards rat Ar in an in vitro cell free assay measured by fluorescence polarization method,B,BAO_0000186,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL5291721,Nat Commun,2023.0,CHEMBL31,GATIFLOXACIN,CHEMBL31,0,http://www.openphacts.org/units/Nanomolar,3940425,>,1,1,>,AC50,nM,10000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,AC50,uM,UO_0000065,10.0
42476,Not Determined,126521,CHEMBL764438,In vitro inhibitory activity against hepatic stages of Plasmodium yoelii yoelii 265 BY; No data,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1148256,Bioorg Med Chem Lett,2004.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,172944,,1,0,,IC50,nM,,CHEMBL612328,Plasmodium yoelii yoelii,Plasmodium yoelii yoelii,73239.0,,IC50,uM,UO_0000065,
42477,,126522,CHEMBL760246,In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum NF54-R in blood,F,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1148256,Bioorg Med Chem Lett,2004.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,172944,=,1,1,=,IC50,nM,45000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,45.0
42478,,965548,CHEMBL807153,Antibacterial activity was determined against Staphylococcus aureus FDA 209-P strain after incubation at 37 degrees C for 18 h,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC,ug.mL-1,0.013,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.013
42479,,965549,CHEMBL804403,Antibacterial activity was determined against Staphylococcus epidermis 56500 strain after incubation at 37 degrees C for 18 h,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.1
42480,,965550,CHEMBL809336,Antibacterial activity was determined against Streptococcus pneumoniae J-24 strain after incubation at 37 degrees C for 18 h,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.025
42481,,965551,CHEMBL808948,Antibacterial activity was determined against Streptococcus pyogenes G-36 strain after incubation at 37 degrees C for 18 h,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.2
42482,,965552,CHEMBL812014,Antibacterial activity was determined against Streptococcus mitis IID685 strain after incubation at 37 degrees C for 18 h,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.1
42483,,965553,CHEMBL679636,Antibacterial activity was determined against Enterococcus faecalis ATCC 19433 strain after incubation at 37 degrees C for 18 h,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.2
42484,,965554,CHEMBL674794,Antibacterial activity was determined against Escherichia coli NIHJ strain after incubation at 37 degrees C for 18 h,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,<=,1,1,<=,MIC,ug.mL-1,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.003
42485,,965555,CHEMBL700140,Antibacterial activity was determined against Klebsiella pneumoniae type II strain after incubation at 37 degrees C for 18 h,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.025
42486,,965556,CHEMBL772626,Antibacterial activity was determined against Pseudomonas aeruginosa PAO1 strain after incubation at 37 degrees C for 18 h,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.2
42487,,965557,CHEMBL810350,Antibacterial activity was determined against clinically isolated Levofloxacin-methicillin resistant Staphylococcus aureus (LVFX-r MRSA) strains (74 strains),F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
42488,,965558,CHEMBL807739,Antibacterial activity was determined against clinically isolated Levofloxacin-methicillin resistant Staphylococcus aureus (LVFX-r MRSA) strains (74 strains),F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
42489,,965559,CHEMBL814672,Antibacterial activity was determined against clinically isolated penicillin resistant Streptococcus pneumoniae (PRSP) strains (50 strains),F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.12
42490,,965560,CHEMBL817379,Antibacterial activity was determined against clinically isolated penicillin resistant Streptococcus pneumoniae (PRSP) strains (50 strains),F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.25
42491,,965561,CHEMBL673549,Antibacterial activity was determined against clinically isolated vancomycin-A resistant enterococci (VRE) strains (33 strains),F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,MIC50,ug ml-1,UO_0000274,16.0
42492,,965562,CHEMBL674199,Antibacterial activity was determined against clinically isolated vancomycin-A resistant enterococci (VRE) strains (33 strains),F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,MIC90,ug ml-1,UO_0000274,32.0
42493,,965563,CHEMBL673551,Antibacterial activity was determined against clinically isolated vancomycin-B resistant enterococci (VRE) strains (10 strains),F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,MIC50,ug ml-1,UO_0000274,2.0
42494,,965564,CHEMBL878269,Antibacterial activity was determined against clinically isolated vancomycin-B resistant enterococci (VRE) strains (10 strains),F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145781,J Med Chem,2003.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1753,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,MIC90,ug ml-1,UO_0000274,8.0
42495,,1454849,CHEMBL830505,Antibacterial activity against Staphylococcus aureus FDA 209P was determined,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137908,Bioorg Med Chem Lett,2004.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,375998,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.02
42496,,1454850,CHEMBL834601,Antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) 870307 was determined,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137908,Bioorg Med Chem Lett,2004.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,375998,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
42497,,1454851,CHEMBL830606,Antibacterial activity against Staphylococcus epidermidis 56500 was determined,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137908,Bioorg Med Chem Lett,2004.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,375998,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.1
42498,,1454852,CHEMBL834600,Antibacterial activity against Penicillin-resistant Streptococcus pneumoniae (PRSP) J-24 was determined,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137908,Bioorg Med Chem Lett,2004.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,375998,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.02
42499,,1454853,CHEMBL831512,Antibacterial activity against Streptococcus pyogenes G-36 was determined,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137908,Bioorg Med Chem Lett,2004.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,375998,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.2
42500,,1454854,CHEMBL831419,Antibacterial activity against Streptococcus mitis IID685 was determined,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137908,Bioorg Med Chem Lett,2004.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,375998,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.1
42501,,1454855,CHEMBL831328,Antibacterial activity against Enterococcus faecalis ATCC 19433 was determined,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137908,Bioorg Med Chem Lett,2004.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,375998,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.2
42502,,1454856,CHEMBL831865,Antibacterial activity against Escherichia coli NIHJ was determined,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137908,Bioorg Med Chem Lett,2004.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,375998,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
42503,,1454857,CHEMBL831799,Antibacterial activity against Klebsiella pneumoniae type II was determined,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137908,Bioorg Med Chem Lett,2004.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,375998,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.05
42504,,1495485,CHEMBL830510,Minimum inhibitory concentration against Streptococcus agalactiae ATCC 13813,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.12
42505,,1495580,CHEMBL831781,Minimum inhibitory concentration against Streptococcus sanguis ATCC 10556,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,MIC,ug ml-1,UO_0000274,0.5
42506,,1495581,CHEMBL830805,Minimum inhibitory concentration against Klebsiella pneumoniae ATCC 10031,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.008
42507,,1495582,CHEMBL831389,Minimum inhibitory concentration against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
42508,,1495583,CHEMBL831791,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
42509,,1495584,CHEMBL831421,Minimum inhibitory concentration against Bacteroides vulgatus ATCC 29327,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC,ug ml-1,UO_0000274,0.5
42510,,1495585,CHEMBL835272,Minimum inhibitory concentration against methicillin-resistant Staphylococcus aureus-32,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42511,,1495586,CHEMBL875750,Minimum inhibitory concentration against methicillin-resistant Staphylococcus aureus-33,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42512,,1495587,CHEMBL835005,Minimum inhibitory concentration against methicillin-resistant Staphylococcus aureus-5023,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42513,,1495588,CHEMBL826470,Minimum inhibitory concentration against vancomycin intermediate Staphylococcus aureus MU 3,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
42514,,1495590,CHEMBL830506,Minimum inhibitory concentration against vancomycin intermediate Staphylococcus aureus MU 50,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
42515,,1495591,CHEMBL833615,Minimum inhibitory concentration against vancomycin-resistant Staphylococcus aureus (Hershey),F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
42516,,1495595,CHEMBL836109,Mutant prevention concentration against methicillin resistant Staphylococcus aureus-32 done for 48 h at 37 degree C with compound,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,0,=,MPC,ug ml-1,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MPC,ug ml-1,UO_0000274,10.0
42517,,1495596,CHEMBL836110,Mutant prevention concentration aganist methicillin resistant Staphylococcus aureus-33 done for 48 hr at 37 degree C with compound,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,0,=,MPC,ug ml-1,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MPC,ug ml-1,UO_0000274,10.0
42518,,1495597,CHEMBL831471,Mutant prevention concentration aganist methicillin resistant Staphylococcus aureus-5023 done for 48 hr at 37 degree C with compound,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,0,=,MPC,ug ml-1,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MPC,ug ml-1,UO_0000274,10.0
42519,,1495600,CHEMBL831777,Minimum inhibitory concentration against Staphylococcus aureus ATCC 25923,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42520,,1495607,CHEMBL875746,Minimum inhibitory concentration against Staphylococcus haemolyticus ATCC 29970,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.06
42521,,1495608,CHEMBL830690,Minimum inhibitory concentration against Staphylococcus saprophyticus ATCC 15305,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,0.25
42522,,1495609,CHEMBL830804,Minimum inhibitory concentration against Enterococcus faecalis ATCC 29212,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.25
42523,,1495610,CHEMBL831326,Minimum inhibitory concentration against Streptococcus pneumoniae ATCC 49619,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42524,,1495611,CHEMBL830503,Minimum inhibitory concentration against Streptococcus pneumoniae ATCC 6303,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42525,,1495612,CHEMBL831794,Minimum inhibitory concentration against Streptococcus pyogenes ATCC 19615,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1141145,J Med Chem,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.25
42526,,1689637,CHEMBL865343,Inhibitory activity against Staphylococcus aureus ATCC 29213 wild type Topo 4,B,BAO_0000190,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,1,http://www.openphacts.org/units/Nanomolar,438115,=,1,1,=,IC50,nM,800.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,IC50,uM,UO_0000065,0.8
42527,,1689676,CHEMBL865342,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42528,,1689715,CHEMBL865341,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,0.061,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.061
42529,,1689754,CHEMBL865340,Antibacterial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,0.013,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.013
42530,,1689958,CHEMBL867180,Antibacterial activity against Enterococcus faecium ATCC 49032,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.125
42531,,1690049,CHEMBL867181,Antibacterial activity against Enterococcus faecalis ATCC 29212,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.125
42532,,1690054,CHEMBL867182,Antibacterial activity against Streptococcus pyogenes ATCC 19615,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,0.061,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.061
42533,,1690059,CHEMBL867183,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
42534,,1690064,CHEMBL867184,Antibacterial activity against Haemophilus influenzae type b ACH-0056,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,0.013,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.013
42535,,1690069,CHEMBL867185,Antibacterial activity against Moraxella catarrhalis ATCC 8176,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,0.061,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.061
42536,,1690074,CHEMBL867186,Antibacterial activity against Stenotrophomonas maltophilia ATCC 13637,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,0.031,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,0.031
42537,,1690079,CHEMBL867187,Antibacterial activity against Salmonella Typhimurium ATCC 14028,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,0.061,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.061
42538,,1690084,CHEMBL867188,Antibacterial activity against Klebsiella pneumoniae ATCC 13883,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,0.031,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.031
42539,,1690089,CHEMBL867189,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
42540,,1695217,CHEMBL865595,Antimicrobial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441547,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
42541,,1695254,CHEMBL865596,Antimicrobial activity against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441547,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42542,,1695291,CHEMBL865597,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 700699,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441547,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42543,,1695505,CHEMBL863775,Inhibitory activity against wild type Escherichia coli gyrase,B,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,441547,=,1,1,=,IC50,nM,300.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.3
42544,,1695521,CHEMBL864372,Inhibitory activity against wild type Staphylococcus aureus topoisomerase 4,B,BAO_0000190,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,441547,=,1,1,=,IC50,nM,800.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,IC50,uM,UO_0000065,0.8
42545,,1804016,CHEMBL910493,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139232,J Med Chem,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621376,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
42546,,1804027,CHEMBL910494,Cytotoxicity against human Hep2 cell line after 72 hrs,A,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139232,J Med Chem,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,621376,>,1,1,>,CC50,nM,100000.0,CHEMBL612558,,ADMET,,,CC50,uM,UO_0000065,100.0
42547,,1804196,CHEMBL910518,Cytotoxicity against rat hepatocytes after 48 hrs,F,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139232,J Med Chem,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,621376,>,1,1,>,CC50,nM,100000.0,CHEMBL613362,Rattus norvegicus,Hepatocyte,10116.0,,CC50,uM,UO_0000065,100.0
42548,,1804202,CHEMBL910510,Inhibition of Staphylococcus aureus topoisomerase 4 by decatenation assay,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139232,J Med Chem,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,621376,=,1,1,=,IC50,nM,800.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.8
42549,,1804208,CHEMBL910511,Inhibition of Staphylococcus aureus DNA gyrase by supercoiling assay,B,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139232,J Med Chem,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,621376,=,1,1,=,IC50,nM,28000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,28.0
42550,,1804220,CHEMBL910513,Antibacterial activity against methicillin-sensitive Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139232,J Med Chem,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621376,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42551,,1804226,CHEMBL910514,Antibacterial activity against fluoroquinolone-resistant Staphylococcus aureus 273/T/T/T,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1139232,J Med Chem,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621376,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
42552,,1819119,CHEMBL908583,Antibacterial activity against Streptococcus pyogenes M12 by time-kill curve assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142144,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625626,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,mg/L,UO_0000274,0.125
42553,,1828952,CHEMBL908125,Cytotoxicity against primary human osteoblasts at 400 ug/ml assessed as LDH release after 24 hrs,A,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,625755,=,1,0,=,Activity,%,10.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,10.0
42554,Active,1828964,CHEMBL909771,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA at 10 ug/ml after 48 hrs,F,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,625755,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
42555,,1828967,CHEMBL909772,Increase in lactate production in primary human osteoblasts at 25 to 50 ug/ml by ELISA,F,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,625755,=,1,0,=,Activity,%,10.0,CHEMBL612582,,Osteoblast,,,Activity,%,UO_0000187,10.0
42556,,1829054,CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,1,=,IC50,ug.mL-1,160.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,IC50,ug ml-1,UO_0000274,160.0
42557,,1829055,CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,>,1,1,>,IC50,ug.mL-1,400.0,CHEMBL612582,,Osteoblast,,,IC50,ug ml-1,UO_0000274,400.0
42558,,1829272,CHEMBL912048,Inhibitory activity against azide-resistant Escherichia coli J53,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
42559,,1829278,CHEMBL912049,Inhibitory activity against Escherichia coli 12-1502,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
42560,,1829284,CHEMBL912050,Inhibitory activity against Klebsiella pneumoniae 12-1183,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
42561,,1829290,CHEMBL912051,Inhibitory activity against azide-resistant Escherichia coli J53 T12-1183,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
42562,,1829296,CHEMBL912052,Inhibitory activity against Klebsiella pneumoniae 35,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
42563,,1829302,CHEMBL912053,Inhibitory activity against azide-resistant Escherichia coli J53 T35,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
42564,,1829308,CHEMBL912054,Inhibitory activity against Klebsiella pneumoniae 07-006,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
42565,,1829314,CHEMBL912055,Inhibitory activity against azide-resistant Escherichia coli J53 T07-006,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
42566,,1829320,CHEMBL912056,Inhibitory activity against Klebsiella pneumoniae 03-222,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
42567,,1829326,CHEMBL912057,Inhibitory activity against azide-resistant Escherichia coli J53 T03-222,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
42568,,1829332,CHEMBL912058,Inhibitory activity against azide-resistant Escherichia coli J53 T12-1502,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
42569,,1833792,CHEMBL908132,Antimicrobial activity against Streptococcus pneumoniae R6,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42570,,1833796,CHEMBL908133,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42571,,1833800,CHEMBL908134,Antimicrobial activity agaisnt Streptococcus pneumoniae R6 transformants with parC S79Y mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42572,,1833804,CHEMBL908135,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42573,,1833808,CHEMBL908136,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
42574,,1833812,CHEMBL908137,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81Y mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
42575,,1833816,CHEMBL908138,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA E85K mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42576,,1833820,CHEMBL908139,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81F mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
42577,,1833824,CHEMBL908140,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA S81F mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
42578,,1833828,CHEMBL908141,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA E85K mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
42579,,1833832,CHEMBL908142,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81F mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
42580,,1833836,CHEMBL908143,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81Y mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42581,,1833840,CHEMBL908144,Antimicrobial activity agaisnt Streptococcus pneumoniae R6 transformants with parC S79F and gyrA E85K mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
42582,,1833844,CHEMBL908145,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81F mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42583,,1833848,CHEMBL908146,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81Y mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42584,,1833852,CHEMBL908147,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA E85K mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42585,,1833856,CHEMBL908148,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81F mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42586,,1833860,CHEMBL908149,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81Y mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42587,,1833864,CHEMBL908150,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA E85K mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
42588,,1834933,CHEMBL906970,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3009 with GyrA S81F and ParC D83N mutation after 19 passages by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
42589,,1834935,CHEMBL906972,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 1076 with ParC S79Y mutation after 35 passages by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
42590,,1834938,CHEMBL906975,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3665 with GyrA S81Y mutation after 38 passages by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42591,,1834940,CHEMBL906977,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3676 with GyrA E85G, GyrB S478I and ParC S79Y mutation after 50 passages by macrodilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
42592,,1834942,CHEMBL906979,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3243 after 20 passages by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42593,,1834945,CHEMBL906982,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 19 with GyrA S81F mutation after 32 passages by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42594,,1834947,CHEMBL906984,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 24 with GyrA S81Y, GyrB P413S and ParC S79F mutation after 50 passages by macrodilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42595,,1834965,CHEMBL908694,Antibacterial activity against levofloxacin resistance selected Streptococcus pneumoniae 3009 with GyrA S81Y and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42596,,1834977,CHEMBL908695,Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 3009 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
42597,,1834994,CHEMBL908696,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3009 with GyrA S81F and ParC D83N mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42598,,1835012,CHEMBL908697,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3009 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
42599,,1835043,CHEMBL908698,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 1076 with ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42600,,1835057,CHEMBL908699,Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 1076 with ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42601,,1835070,CHEMBL908700,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 1077 with 23S rRNA A2058G mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42602,,1835084,CHEMBL908701,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3665 with GyrA S81Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42603,,1835094,CHEMBL908702,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3665 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
42604,,1835113,CHEMBL908703,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3676 with GyrA E85G, GyrB S478I and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
42605,,1835135,CHEMBL908704,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3676 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42606,,1835145,CHEMBL908705,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3243 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42607,,1835155,CHEMBL908706,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 3243 with L22 insertion 93SFRPRA94 mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42608,,1835165,CHEMBL908707,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3243 with 23S rRNA A2059T mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
42609,,1835175,CHEMBL908708,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 19 with GyrA S81F mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
42610,,1835185,CHEMBL908709,Antibacterial activity against levofloxacin resistance selected Streptococcus pneumoniae 19 with GyrA S81Y and ParC D83Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42611,,1835195,CHEMBL908127,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 24 with GyrA S81Y, GyrB P413S and ParC S79F mutation after 10 antibiotic-free subcultures by macrodilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42612,,1835205,CHEMBL908128,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 2527 after 10 antibiotic-free subcultures by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42613,,1835215,CHEMBL908129,"Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 37 with GyrA S81Y, GyrB E474K and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
42614,,1835586,CHEMBL917049,Antimicrobial activity against Mycobacterium tuberculosis H37Rv in 7H9 broth,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626031,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.5
42615,,1835587,CHEMBL917957,Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in mouse J774A.1 macrophages,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626031,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,1.0
42616,,1835617,CHEMBL917959,Antimicrobial activity against Mycobacterium tuberculosis H3Rv on day 7,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,626031,=,1,0,=,log10CFU/ml,,3.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,log10CFU/ml,,,3.0
42617,Active,1835637,CHEMBL917960,Bactericidal activity in Mycobacterium tuberculosis H37Rv on day 1,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,626031,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
42618,Active,1835638,CHEMBL917961,Bactericidal activity in Mycobacterium tuberculosis H37Rv on day 7,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,626031,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
42619,Active,1835639,CHEMBL917962,Bactericidal activity in Mycobacterium tuberculosis H37Rv on day 14,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,626031,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
42620,,1835665,CHEMBL917972,"Ratio of fraction AUC in Mycobacterium tuberculosis infected BALB/c mouse to MIC in Mycobacterium tuberculosis infected BALB/c mouse model at 38 to 19000 mg/kg, po",A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,626031,=,1,0,=,RatioAUC/MIC,,0.11,CHEMBL612558,,ADMET,,,RatioAUC/MIC,,,0.11
42621,,1835667,CHEMBL917973,"Ratio of fraction Cmax in Mycobacterium tuberculosis infected BALB/c mouse to MIC in Mycobacterium tuberculosis infected BALB/c mouse model at 38 to 19000 mg/kg, po",A,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,626031,=,1,0,=,Ratio,,1.0,CHEMBL612558,,ADMET,,,Ratio,,,1.0
42622,,1836914,CHEMBL856454,Antibacterial activity against Streptococcus pneumoniae 3009 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42623,,1836916,CHEMBL856455,Antibacterial activity against Streptococcus pneumoniae 1076 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42624,,1836923,CHEMBL856457,Antibacterial activity against Streptococcus pneumoniae 3665 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
42625,,1836925,CHEMBL856459,Antibacterial activity against Streptococcus pneumoniae 3676 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42626,,1836927,CHEMBL856458,Antibacterial activity against Streptococcus pneumoniae 3243 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
42627,,1836930,CHEMBL856460,Antibacterial activity against Streptococcus pneumoniae 19 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
42628,,1836932,CHEMBL856461,Antibacterial activity against Streptococcus pneumoniae 24 by macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42629,,1847302,CHEMBL918716,Antibacterial activity against Staphylococcus aureus SA1199B overexpressing NorA at 5 ug by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142063,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,631996,=,1,1,=,IZ,mm,31.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,31.0
42630,,1847485,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC50,ug ml-1,UO_0000274,0.125
42631,,1847491,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC90,ug ml-1,UO_0000274,0.25
42632,,1847499,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,MBC50,ug ml-1,0.125,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MBC50,ug ml-1,UO_0000274,0.125
42633,,1847507,CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,MBC90,ug ml-1,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MBC90,ug ml-1,UO_0000274,0.25
42634,,1847521,CHEMBL919668,Increase in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,632006,=,1,0,=,Activity,%,27.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,%,UO_0000187,27.0
42635,,1847529,CHEMBL919669,Decrease in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,632006,=,1,0,=,Activity,%,40.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,%,UO_0000187,40.0
42636,,1847542,CHEMBL919653,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL856 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,0.25
42637,,1847550,CHEMBL919654,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2394 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,2.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,2.0
42638,,1847558,CHEMBL919655,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2414 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,0.5
42639,,1847566,CHEMBL919656,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2492 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,0.25
42640,,1847574,CHEMBL919657,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2526 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,0.5
42641,,1847582,CHEMBL919658,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2554 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,<=,1,0,<=,BBC,ug ml-1,0.125,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,0.125
42642,,1847590,CHEMBL919659,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2588 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,0.5
42643,,1847598,CHEMBL919660,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2622 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,2.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,2.0
42644,,1847606,CHEMBL919661,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2639 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,0.25
42645,,1847614,CHEMBL919662,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2640 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,2.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,2.0
42646,,1847622,CHEMBL919663,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2664 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,<=,1,0,<=,BBC,ug ml-1,0.125,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,0.125
42647,,1847630,CHEMBL919664,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5204 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,0.5
42648,,1847638,CHEMBL919665,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5254 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,0.5
42649,,1847646,CHEMBL919666,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5256 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,BBC,ug ml-1,1.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,1.0
42650,,1847654,CHEMBL919667,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5258 biofilms after 24 hrs assessed as bacterial regrowth,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,<=,1,0,<=,BBC,ug ml-1,0.125,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,BBC,ug ml-1,UO_0000274,0.125
42651,,1847662,CHEMBL919110,Effect on biofilm formation of Staphylococcus lugdunensis assessed as percent non-biofilm forming isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,632006,=,1,0,=,Activity,%,33.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,%,UO_0000187,33.0
42652,Active,1847833,CHEMBL920064,"Reduction of lung lesions in Mycobacterium tuberculosis H37Rv infected Swiss mouse at 100 mg/kg, po for 5 days/week after 2 months",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142073,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,632057,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
42653,,1848140,CHEMBL916441,Antimicrobial activity against Nocardia cyriacigeorgica after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,MIC,ug.mL-1,6e-05,CHEMBL4296583,Nocardia cyriacigeorgica,Nocardia cyriacigeorgica,135487.0,,MIC,ug/L,UO_0000274,0.06
42654,,1848148,CHEMBL916442,Antimicrobial activity against Nocardia farcinica after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,MIC,ug.mL-1,6e-05,CHEMBL613232,Nocardia farcinica,Nocardia farcinica,37329.0,,MIC,ug/L,UO_0000274,0.06
42655,,1848156,CHEMBL916443,Antimicrobial activity against Nocardia otitidiscaviarum after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,MIC,ug.mL-1,6e-05,CHEMBL613233,Nocardia otitidiscaviarum,Nocardia otitidiscaviarum,1823.0,,MIC,ug/L,UO_0000274,0.06
42656,,1848163,CHEMBL916444,Antimicrobial activity against Nocardia abscessus after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,1.0
42657,,1848172,CHEMBL916445,Antimicrobial activity against Nocardia beijingensis after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,MIC,ug.mL-1,6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.06
42658,,1848180,CHEMBL916446,Antimicrobial activity against Nocardia nova after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL612977,Nocardia nova,Nocardia nova,37330.0,,MIC,ug/L,UO_0000274,2.0
42659,,1848189,CHEMBL916447,Antimicrobial activity against Nocardia veterana after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.5
42660,,1848197,CHEMBL916448,Antimicrobial activity against Nocardia transvalensis after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,=,1,1,=,MIC,ug.mL-1,0.00012,CHEMBL613234,Nocardia transvalensis,Nocardia transvalensis,37333.0,,MIC,ug/L,UO_0000274,0.12
42661,,1848205,CHEMBL916449,Antimicrobial activity against Nocardia carnea after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,MIC,ug.mL-1,6e-05,CHEMBL4296582,Nocardia carnea,Nocardia carnea,37328.0,,MIC,ug/L,UO_0000274,0.06
42662,,1848213,CHEMBL916450,Antimicrobial activity against Nocardia brasiliensis after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,MIC,ug.mL-1,6e-05,CHEMBL612976,Nocardia brasiliensis,Nocardia brasiliensis,37326.0,,MIC,ug/L,UO_0000274,0.06
42663,,1848220,CHEMBL916451,Antimicrobial activity against Nocardia sp. after 72 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,MIC,ug.mL-1,6e-05,CHEMBL612979,Nocardia sp.,Nocardia sp.,1821.0,,MIC,ug/L,UO_0000274,0.06
42664,,1850154,CHEMBL920752,Antimicrobial susceptibility against Haemophilus influenzae A isolate with GyrA Glu83Cys and AcrR 97stop codon mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.03
42665,,1850157,CHEMBL920753,"Antimicrobial susceptibility against Haemophilus influenzae A1 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
42666,,1850160,CHEMBL920754,"Antimicrobial susceptibility against Haemophilus influenzae A2 with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
42667,,1850163,CHEMBL920755,"Antimicrobial susceptibility against Haemophilus influenzae A3 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
42668,,1850166,CHEMBL920756,"Antimicrobial susceptibility against Haemophilus influenzae A4 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,2.0
42669,,1850169,CHEMBL920196,Antimicrobial susceptibility against Haemophilus influenzae B isolate with AcrR Leu31His mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.06
42670,,1850172,CHEMBL920197,Antimicrobial susceptibility against Haemophilus influenzae B1 isolate with GyrA Asp88Tyr and AcrR Leu31His mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.25
42671,,1850175,CHEMBL920198,Antimicrobial susceptibility against Haemophilus influenzae B2 isolate with GyrA Asp88Tyr and AcrR Leu31His mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.25
42672,,1850178,CHEMBL920199,Antimicrobial susceptibility against Haemophilus influenzae C isolate with AcrR Leu31His and Arg34Glu mutation,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.03
42673,,1850181,CHEMBL920200,"Antimicrobial susceptibility against Haemophilus influenzae C1 isolate with GyrA Asp88Asn, AcrR Leu31His and Arg34Glu mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.12
42674,,1850184,CHEMBL920201,"Antimicrobial susceptibility against Haemophilus influenzae C2 isolate with GyrA Asp88Asn, AcrR Leu31His and Arg34Glu mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,4.0
42675,,1850187,CHEMBL920202,"Antimicrobial susceptibility against Haemophilus influenzae C3 isolate with GyrA Asp88Asn, ParC Ser84Ile, AcrR Leu31His and Arg34Glu mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,4.0
42676,,1850190,CHEMBL920203,"Antimicrobial susceptibility against Haemophilus influenzae D isolate with AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.03
42677,,1850193,CHEMBL920204,"Antimicrobial susceptibility against Haemophilus influenzae D1 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
42678,,1850196,CHEMBL920205,"Antimicrobial susceptibility against Haemophilus influenzae D2 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,2.0
42679,,1850199,CHEMBL920206,"Antimicrobial susceptibility against Haemophilus influenzae D3 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,2.0
42680,,1850202,CHEMBL920207,"Antimicrobial susceptibility against Haemophilus influenzae D4 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,2.0
42681,,1866400,CHEMBL920153,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed by relative light units after 7 days,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,634689,=,1,1,=,MIC,nM,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.5
42682,,1866429,CHEMBL920154,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed as bacterial density after 7 days,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,634689,<=,1,1,<=,MIC,nM,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.5
42683,,1866458,CHEMBL920155,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as relative light unit after 11 days by LORA assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,634689,=,1,1,=,MIC,nM,15900.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,15.9
42684,,1866487,CHEMBL920156,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as bacterial density after 10 days,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,634689,<=,1,1,<=,MIC,nM,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.5
42685,,1866841,CHEMBL915677,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 75 mg,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,634949,=,1,0,=,fAUC/MIC,,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,24.0
42686,,1866871,CHEMBL915676,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 50 mg,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,634949,=,1,0,=,fAUC/MIC,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,16.0
42687,,1866872,CHEMBL914192,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 50 mg,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,634949,=,1,0,=,fAUC/MIC,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,32.0
42688,,1866873,CHEMBL914191,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 400 mg,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,634949,=,1,0,=,fAUC/MIC,,236.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,236.0
42689,,1866874,CHEMBL914187,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 100 mg,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,634949,=,1,0,=,fAUC/MIC,,63.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,63.0
42690,,1867238,CHEMBL914132,Susceptibility of penicillin-resistant Streptococcus pneumoniae 335 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
42691,,1867243,CHEMBL914133,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42692,,1867250,CHEMBL914134,Effect on 0.5 ug/ml sitofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42693,,1867255,CHEMBL914135,Effect on 1 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
42694,,1867259,CHEMBL915624,Effect on 16 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
42695,,1867264,CHEMBL915625,Effect on 16 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
42696,,1867269,CHEMBL915626,Susceptibility of penicillin-resistant Streptococcus pneumoniae 334 by by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
42697,,1867273,CHEMBL914661,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
42698,,1867277,CHEMBL915629,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42699,,1867281,CHEMBL915630,Effect on 1 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
42700,,1867285,CHEMBL915631,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
42701,,1867289,CHEMBL915632,Effect on 32 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42702,,1867294,CHEMBL915633,Susceptibility of penicillin-resistant Streptococcus pneumoniae 216 by by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
42703,,1867298,CHEMBL915634,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
42704,,1867304,CHEMBL915635,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
42705,,1867308,CHEMBL915636,Effect on 2 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
42706,,1867312,CHEMBL915637,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42707,,1867320,CHEMBL915638,Effect on 32 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
42708,,1867329,CHEMBL915639,Susceptibility of penicillin-resistant Streptococcus pneumoniae 217 by by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42709,,1867336,CHEMBL915640,Effect on 0.03 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42710,,1867341,CHEMBL915641,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
42711,,1867345,CHEMBL915642,Effect on 0.5 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42712,,1867353,CHEMBL915643,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
42713,,1867357,CHEMBL915033,Effect on 8 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
42714,,1867363,CHEMBL915034,Susceptibility of penicillin-resistant Streptococcus pneumoniae 218 by by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
42715,,1867373,CHEMBL915035,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42716,,1867384,CHEMBL915036,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42717,,1867389,CHEMBL914130,Effect on 2 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42718,,1867393,CHEMBL915037,Effect on 16 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42719,,1867398,CHEMBL915038,Effect on 16 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
42720,,1867476,CHEMBL914131,Susceptibility of methicillin-sensitive/resistant Staphylococcus aureus single-step mutant by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
42721,,1867490,CHEMBL915039,Susceptibility of vancomycin-resistant Enterococcus species single-step mutant by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,8.0
42722,,1867511,CHEMBL915040,Susceptibility of drug-selected vancomycin-resistant Enterococcus species mutant by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,MIC,ug.mL-1,64000.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,mg/ml,UO_0000274,64.0
42723,,1868292,CHEMBL919811,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634867,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42724,Not Determined,1868294,CHEMBL919277,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,634867,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
42725,,1868298,CHEMBL919807,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634867,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
42726,Not Determined,1868303,CHEMBL919813,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,634867,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
42727,,1868304,CHEMBL919817,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA643 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634867,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
42728,,1868320,CHEMBL919278,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA678 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634867,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
42729,,1868342,CHEMBL919279,Antibacterial activity against Staphylococcus aureus Mu50 at pH 5,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634867,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
42730,,1869730,CHEMBL914169,Peak free concentration at 800 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,Activity,ug ml-1,4.46,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,4.46
42731,,1869731,CHEMBL914160,Peak free concentration at 50 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,Activity,ug ml-1,0.3,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,0.3
42732,,1869732,CHEMBL914161,Peak free concentration at 75 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,Activity,ug ml-1,0.45,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,0.45
42733,,1869733,CHEMBL914730,Peak free concentration at 100 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,Activity,ug ml-1,0.6,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,0.6
42734,,1869734,CHEMBL914158,Peak free concentration at 200 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,Activity,ug ml-1,1.1,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,1.1
42735,,1869735,CHEMBL914159,Peak free concentration at 400 mg/24 hrs regimen in vitro PK model,A,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,Activity,ug ml-1,2.48,CHEMBL612558,,ADMET,,,Activity,ug ml-1,UO_0000274,2.48
42736,,1869812,CHEMBL914170,Half life at 100 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,T1/2,hr,12.02,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,12.02
42737,,1869813,CHEMBL914172,Half life at 200 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,T1/2,hr,11.9,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,11.9
42738,,1869819,CHEMBL914173,Half life at 400 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,T1/2,hr,11.66,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,11.66
42739,,1869857,CHEMBL914174,Half life at 50 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,T1/2,hr,12.33,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,12.33
42740,,1869858,CHEMBL914175,Half life at 75 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,T1/2,hr,12.42,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,12.42
42741,,1869923,CHEMBL914183,Half life at 800 mg/24 hrs regimen in vitro PK model,A,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,T1/2,hr,12.4,CHEMBL612558,,ADMET,,,t1/2,hr,UO_0000032,12.4
42742,,1870000,CHEMBL916616,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 32 after 24 to 48 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
42743,,1870001,CHEMBL915674,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 32 after 72 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.19
42744,,1870002,CHEMBL916618,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 32 after 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.75
42745,,1870003,CHEMBL916619,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 63 after 24 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
42746,,1870004,CHEMBL916620,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 114 after 24 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
42747,,1870005,CHEMBL916621,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 236 after 24 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
42748,,1870006,CHEMBL916622,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 449 after 24 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
42749,,1870007,CHEMBL916623,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 16 after 24 to 48 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
42750,,1870008,CHEMBL916624,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 24 after 24 to 48 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
42751,,1870009,CHEMBL916625,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 31 after 24 to 96 hrs in pharmacodynamic model,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
42752,,1870010,CHEMBL916626,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation and gyrA S81Y mutation at fAUC/MIC of 16 after 72 hrs in pharmacodynamic model",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,4.0
42753,,1870011,CHEMBL916627,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation and gyrA S81Y mutation at fAUC/MIC of 16 after 96 hrs in pharmacodynamic model",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,4.0
42754,,1870012,CHEMBL916628,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation and gyrA S114G mutation at fAUC/MIC of 24 after 72 hrs in pharmacodynamic model",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.38
42755,,1870013,CHEMBL916089,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation and gyrA S114G mutation at fAUC/MIC of 24 after 96 hrs in pharmacodynamic model",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.5
42756,,1870014,CHEMBL914153,Susceptibility of Streptococcus pneumoniae ATCC 49619 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.025
42757,,1870015,CHEMBL914732,Susceptibility of Streptococcus pneumoniae BSP-2443 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.025
42758,,1870057,CHEMBL914190,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 200 mg,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,634949,=,1,0,=,fAUC/MIC,,114.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,114.0
42759,,1870064,CHEMBL915678,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 100 mg,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,634949,=,1,0,=,fAUC/MIC,,31.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,31.0
42760,,1870116,CHEMBL914731,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 800 mg,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,634949,=,1,0,=,fAUC/MIC,,449.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,fAUC/MIC,,,449.0
42761,,2123032,CHEMBL936035,Antimicrobial activity against Bacteroides fragilis isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC,ug.mL-1,1.83,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC,ug ml-1,UO_0000274,1.83
42762,,2123033,CHEMBL936035,Antimicrobial activity against Bacteroides fragilis isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC90,ug ml-1,UO_0000274,8.0
42763,,2123044,CHEMBL936957,Antimicrobial activity against Bacteroides distasonis isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC,ug.mL-1,2.32,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC,ug ml-1,UO_0000274,2.32
42764,,2123045,CHEMBL936957,Antimicrobial activity against Bacteroides distasonis isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC90,ug ml-1,UO_0000274,16.0
42765,,2123055,CHEMBL936958,Antimicrobial activity against Bacteroides ovatus isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC,ug.mL-1,5.49,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,MIC,ug ml-1,UO_0000274,5.49
42766,,2123056,CHEMBL936958,Antimicrobial activity against Bacteroides ovatus isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,MIC90,ug ml-1,UO_0000274,32.0
42767,,2123065,CHEMBL936959,Antimicrobial activity against Bacteroides thetaiotaomicron isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC,ug.mL-1,3.71,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC,ug ml-1,UO_0000274,3.71
42768,,2123066,CHEMBL936959,Antimicrobial activity against Bacteroides thetaiotaomicron isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC90,ug ml-1,UO_0000274,32.0
42769,,2123077,CHEMBL936960,Antimicrobial activity against Bacteroides uniformis isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC,ug.mL-1,5.57,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,MIC,ug ml-1,UO_0000274,5.57
42770,,2123078,CHEMBL936960,Antimicrobial activity against Bacteroides uniformis isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,MIC90,ug ml-1,UO_0000274,32.0
42771,,2123089,CHEMBL936961,Antimicrobial activity against Bacteroides vulgatus isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC,ug.mL-1,7.92,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC,ug ml-1,UO_0000274,7.92
42772,,2123090,CHEMBL936961,Antimicrobial activity against Bacteroides vulgatus isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC90,ug ml-1,UO_0000274,64.0
42773,,2123101,CHEMBL936962,Antimicrobial activity against Bacteroides caccae isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC,ug.mL-1,3.85,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC,ug ml-1,UO_0000274,3.85
42774,,2123102,CHEMBL936962,Antimicrobial activity against Bacteroides caccae isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC90,ug ml-1,UO_0000274,32.0
42775,,2123113,CHEMBL936963,Antimicrobial activity against Bacteroides eggerthii isolates by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC,ug.mL-1,3.85,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,3.85
42776,,2123114,CHEMBL936963,Antimicrobial activity against Bacteroides eggerthii isolates by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,32.0
42777,,2123125,CHEMBL936964,Antimicrobial activity against Bacteroides stercoris isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC,ug.mL-1,3.85,CHEMBL614750,Bacteroides stercoris,Bacteroides stercoris,46506.0,,MIC,ug ml-1,UO_0000274,3.85
42778,,2123126,CHEMBL936964,Antimicrobial activity against Bacteroides stercoris isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614750,Bacteroides stercoris,Bacteroides stercoris,46506.0,,MIC90,ug ml-1,UO_0000274,32.0
42779,,2123137,CHEMBL936965,Antimicrobial activity against Bacteroides merdae isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC,ug.mL-1,3.85,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,MIC,ug ml-1,UO_0000274,3.85
42780,,2123138,CHEMBL936965,Antimicrobial activity against Bacteroides merdae isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,MIC90,ug ml-1,UO_0000274,32.0
42781,,2123148,CHEMBL936966,Antimicrobial activity against Bacteroides fragilis assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,Activity,%,27.3,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,Activity,%,UO_0000187,27.3
42782,,2123154,CHEMBL936967,Antimicrobial activity against Bacteroides distasonis assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,Activity,%,29.2,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,Activity,%,UO_0000187,29.2
42783,,2123160,CHEMBL936968,Antimicrobial activity against Bacteroides ovatus assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,Activity,%,38.3,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,Activity,%,UO_0000187,38.3
42784,,2123165,CHEMBL936969,Antimicrobial activity against Bacteroides thetaiotaomicron assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,Activity,%,26.3,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,Activity,%,UO_0000187,26.3
42785,,2123171,CHEMBL936970,Antimicrobial activity against Bacteroides uniformis assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,Activity,%,38.6,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,Activity,%,UO_0000187,38.6
42786,,2123177,CHEMBL936971,Antimicrobial activity against Bacteroides vulgatus assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,Activity,%,54.7,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,Activity,%,UO_0000187,54.7
42787,,2123183,CHEMBL936972,Antimicrobial activity against Bacteroides caccae assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,Activity,%,36.4,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,Activity,%,UO_0000187,36.4
42788,,2123189,CHEMBL936973,Antimicrobial activity against Bacteroides eggerthii assessed as percent resistant isolates,F,BAO_0001103,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,Activity,%,36.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,36.4
42789,,2123195,CHEMBL936974,Antimicrobial activity against Bacteroides merdae assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,Activity,%,36.4,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,Activity,%,UO_0000187,36.4
42790,,2123201,CHEMBL936034,Antimicrobial activity against Bacteroides stercoris assessed as percent resistant isolates,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,Activity,%,36.4,CHEMBL614750,Bacteroides stercoris,Bacteroides stercoris,46506.0,,Activity,%,UO_0000187,36.4
42791,,2124467,CHEMBL953034,Inhibition of Mycobacterium leprae recombinant DNA gyrase expressed in Escherichia coli assessed as inhibition of pBR322 DNA supercoiling,B,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704408,=,1,1,=,IC50,ug.mL-1,2.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,IC50,ug ml-1,UO_0000274,2.0
42792,Not Determined,2124493,CHEMBL953036,Antibacterial activity against Mycobacterium leprae at 5 ug/mL after 11 to 18 days,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,704408,,1,0,,Activity,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,,,
42793,,2124496,CHEMBL953038,Antibacterial activity in Mycobacterium leprae infected mouse foot-pad model assessed as parasite killing at 150 mg/kg/day after 9 months,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,704408,>,1,0,>,Activity,%,99.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,99.0
42794,,2126517,CHEMBL935009,Antimicrobial activity against Streptococcus pneumoniae WB4 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143816,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702324,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.12
42795,,2127570,CHEMBL938262,Antibacterial activity against Peptostreptococcus anaerobius,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703548,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC50,ug ml-1,UO_0000274,0.125
42796,,2127571,CHEMBL938262,Antibacterial activity against Peptostreptococcus anaerobius,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703548,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC90,ug ml-1,UO_0000274,0.125
42797,,2127582,CHEMBL938263,Antibacterial activity against Peptostreptococcus stomatis,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703548,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.125
42798,,2127583,CHEMBL938263,Antibacterial activity against Peptostreptococcus stomatis,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703548,=,1,1,=,MIC50,ug.mL-1,0.094,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.094
42799,,2127741,CHEMBL938381,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae UAB1 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
42800,,2127742,CHEMBL938381,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae UAB1 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,32.0
42801,,2127745,CHEMBL938382,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae UAB1 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
42802,,2127747,CHEMBL938383,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae N5 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
42803,,2127748,CHEMBL938383,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae N5 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,16.0
42804,,2127751,CHEMBL938384,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae N5 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
42805,,2127753,CHEMBL951356,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae1960 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
42806,,2127754,CHEMBL951356,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae1960 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,32.0
42807,,2127757,CHEMBL951357,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1960 GyrA Ser83Phe/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
42808,,2127759,CHEMBL951358,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1132 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
42809,,2127760,CHEMBL951358,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1132 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,32.0
42810,,2127763,CHEMBL951359,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1132 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
42811,,2127765,CHEMBL951360,Antimicrobial activity against Escherichia coli DH10B expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42812,,2127766,CHEMBL951360,Antimicrobial activity against Escherichia coli DH10B expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,0.06
42813,,2127769,CHEMBL951361,Antimicrobial activity against Escherichia coli DH10B GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
42814,,2127771,CHEMBL951362,Antimicrobial activity against Escherichia coli DH10B/pACYC184 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42815,,2127772,CHEMBL951362,Antimicrobial activity against Escherichia coli DH10B/pACYC184 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,0.06
42816,,2127775,CHEMBL952170,Antimicrobial activity against Escherichia coli DH10B/pACYC184 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
42817,,2127777,CHEMBL952171,Antimicrobial activity against qnrA1 expressing Escherichia coli DH10B expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
42818,,2127778,CHEMBL952171,Antimicrobial activity against qnrA1 expressing Escherichia coli DH10B expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,2.0
42819,,2127781,CHEMBL952172,Antimicrobial activity against qnrA1 expressing Escherichia coli DH10B GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
42820,,2127783,CHEMBL952173,Antimicrobial activity against Escherichia coli J53 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
42821,,2127784,CHEMBL952173,Antimicrobial activity against Escherichia coli J53 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,0.125
42822,,2127787,CHEMBL952174,Antimicrobial activity against Escherichia coli J53 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
42823,,2127789,CHEMBL952175,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pMG252 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
42824,,2127790,CHEMBL952175,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pMG252 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,4.0
42825,,2127793,CHEMBL952176,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pMG252 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
42826,,2127795,CHEMBL952177,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pN5 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
42827,,2127796,CHEMBL952177,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pN5 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,4.0
42828,,2127799,CHEMBL952178,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pN5 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
42829,,2127801,CHEMBL952179,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/p1960 expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
42830,,2127802,CHEMBL952179,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/p1960 expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,4.0
42831,,2127805,CHEMBL952180,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/p1960 GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
42832,,2127807,CHEMBL952181,Antimicrobial activity against Escherichia coli J53/p1132 negative expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
42833,,2127808,CHEMBL952181,Antimicrobial activity against Escherichia coli J53/p1132 negative expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MPC,ug ml-1,UO_0000274,0.25
42834,,2127811,CHEMBL952182,Antimicrobial activity against Escherichia coli J53/p1132 negative GyrA/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
42835,,2127813,CHEMBL952183,Antimicrobial activity against Klebsiella pneumoniae C2 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.125
42836,,2127814,CHEMBL952183,Antimicrobial activity against Klebsiella pneumoniae C2 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,4.0
42837,,2127817,CHEMBL952184,Antimicrobial activity against Klebsiella pneumoniae C2 GyrA Ser83Phe/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
42838,,2127819,CHEMBL952185,Antimicrobial activity against Klebsiella pneumoniae C2/pMG252 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
42839,,2127820,CHEMBL952185,Antimicrobial activity against Klebsiella pneumoniae C2/pMG252 GyrA Ser83Phe mutant expressing porins by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,MPC,ug ml-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MPC,ug ml-1,UO_0000274,32.0
42840,,2127823,CHEMBL952186,Antimicrobial activity against Klebsiella pneumoniae C2/pMG252 GyrA Ser83Phe/ParC mutant expressing porins by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
42841,,2345554,CHEMBL955639,Antimicrobial activity against Vibrio splendidus 12B01 expressing plasmid-mediated QnrS-like quinolone resistance determinants,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613176,Vibrio splendidus,Vibrio splendidus,29497.0,,MIC,ug ml-1,UO_0000274,0.25
42842,,2345555,CHEMBL955640,Antimicrobial activity against Vibrio splendidus LGP32 expressing plasmid-mediated QnrS-like quinolone resistance determinants,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613176,Vibrio splendidus,Vibrio splendidus,29497.0,,MIC,ug ml-1,UO_0000274,0.25
42843,,2345556,CHEMBL956419,Antimicrobial activity against Escherichia coli TOP10 harbouring pVS1 expressing quinolone resistant Vibrio splendidus 12B01 QnrVS1 gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
42844,,2345557,CHEMBL956420,Antimicrobial activity against Escherichia coli TOP10 harbouring pVS2 expressing quinolone resistant Vibrio splendidus LGP32 QnrVS2 gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
42845,,2345558,CHEMBL956421,Antimicrobial activity against Escherichia coli TOP10 harbouring pS1 plasmid expressing quinolone resistant QnrS1 gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
42846,,2345559,CHEMBL956422,Antimicrobial activity against Escherichia coli TOP10 harbouring pS2 plasmid expressing quinolone resistant QnrS2 gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
42847,,2345560,CHEMBL956423,Antimicrobial activity against Escherichia coli TOP10 harbouring p0 plasmid expressing pCR-BluntII-TOPO,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,<,1,1,<,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
42848,,2345561,CHEMBL956424,Antimicrobial activity against Escherichia coli TOP10,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,<,1,1,<,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
42849,,2347410,CHEMBL957902,Antibacterial activity against Escherichia coli C600Rif by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.064
42850,,2347417,CHEMBL957904,Antibacterial activity against Escherichia coli C600Rif in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
42851,,2347424,CHEMBL957905,Antibacterial activity against Escherichia coli C600Rif in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
42852,,2347431,CHEMBL957906,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.094,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.094
42853,,2347438,CHEMBL957907,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
42854,,2347445,CHEMBL957908,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
42855,,2347452,CHEMBL957909,Antibacterial activity against Escherichia coli TOP10 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
42856,,2347459,CHEMBL957910,Antibacterial activity against Escherichia coli TOP10 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42857,,2347466,CHEMBL957911,Antibacterial activity against Escherichia coli TOP10 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42858,,2347473,CHEMBL957912,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
42859,,2347480,CHEMBL957913,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42860,,2347487,CHEMBL957914,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42861,,2347494,CHEMBL957915,Antibacterial activity against Escherichia coli TOP10 containing pAT851 plasmid by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
42862,,2347501,CHEMBL957916,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42863,,2347508,CHEMBL957917,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42864,,2348396,CHEMBL957952,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
42865,,2348397,CHEMBL957953,Antibacterial activity against Staphylococcus aureus ACH-0204 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
42866,,2348398,CHEMBL957954,Antibacterial activity against Staphylococcus aureus ACH-0206 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
42867,,2348399,CHEMBL957955,Antibacterial activity against Staphylococcus aureus ACH-0221 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
42868,,2348400,CHEMBL957956,Antibacterial activity against Staphylococcus aureus ACH-0216 isolate with grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
42869,,2348401,CHEMBL957963,"Antibacterial activity against Staphylococcus aureus ACH-0129 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
42870,,2348402,CHEMBL957961,"Antibacterial activity against Staphylococcus aureus ACH-0192 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
42871,,2348403,CHEMBL957957,Antibacterial activity against Staphylococcus aureus ACH-0218 isolate with grlA Glu84Lys mutant after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
42872,,2348404,CHEMBL957958,Antibacterial activity against Staphylococcus aureus ACH-0126 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
42873,,2348405,CHEMBL957959,Antibacterial activity against Staphylococcus aureus ACH-0210 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
42874,,2348406,CHEMBL957960,"Antibacterial activity against Staphylococcus aureus ACH-0186 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
42875,,2348407,CHEMBL957962,"Antibacterial activity against Staphylococcus aureus ACH-0203 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
42876,,2348408,CHEMBL957964,"Antibacterial activity against Staphylococcus aureus ACH-0129 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
42877,,2348409,CHEMBL954764,"Antibacterial activity against Staphylococcus aureus ACH-0201 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
42878,,2348410,CHEMBL954765,"Antibacterial activity against Staphylococcus aureus ACH-0141 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
42879,,2348411,CHEMBL957214,Antibacterial activity against Staphylococcus aureus ATCC 33591 isolate after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
42880,,2348412,CHEMBL957215,Antibacterial activity against Staphylococcus aureus NY2746 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
42881,,2348413,CHEMBL957216,"Antibacterial activity against Staphylococcus aureus ATCC 700699 isolate with gyrA Ser84Leu, Glu409Lys and grlA Ser80Phe mutant after 24 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
42882,,2348414,CHEMBL957217,"Antibacterial activity against Staphylococcus aureus BSA643 isolate with gyrA Ser84Leu and grlA Ser80Tyr, Glu84Gly mutant after 24 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
42883,,2348415,CHEMBL957218,"Antibacterial activity against Staphylococcus aureus BSA678 isolate with gyrA Ser84Leu, Ser85Pro and grlA Ser80Phe, Glu84Gly mutant after 24 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
42884,,2348416,CHEMBL957219,"Antibacterial activity against Staphylococcus aureus ACH-0231 isolate with gyrA Ser84Leu, Glu88Lys and grlA Ser80Tyr, Glu84Gly mutant after 24 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
42885,,2348452,CHEMBL957238,Inhibition of Staphylococcus aureus wild-type DNA gyrase supercoiling activity assessed as effect on conversion of relaxed pBR322 DNA to supercoiled form,B,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,793359,=,1,1,=,IC50,nM,27500.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,27.5
42886,,2348453,CHEMBL957239,Inhibition of Staphylococcus aureus DNA gyrase gyrA S84L mutant supercoiling activity assessed as effect on conversion of relaxed pBR322 DNA to supercoiled form,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,793359,=,1,1,=,IC50,nM,227000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,IC50,uM,UO_0000065,227.0
42887,,2348454,CHEMBL957240,Inhibition of Staphylococcus aureus wild-type topoisomerase 4 decatenation activity assessed as unlinking of DNA microcircles from kinetoplast DNA,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,793359,=,1,1,=,IC50,nM,1000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,1.0
42888,,2348455,CHEMBL957241,Inhibition of Staphylococcus aureus wild-type topoisomerase 4 grlA S80F mutant decatenation activity assessed as unlinking of DNA microcircles from kinetoplast DNA,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,793359,=,1,1,=,IC50,nM,11900.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,11.9
42889,,2348487,CHEMBL960519,Antibacterial activity against Escherichia coli TOP10 containing pS1A plasmid expressing quinolone resistance determinant QnrB4 by E-test,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793030,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
42890,,2348496,CHEMBL960520,Antibacterial activity against Enterobacter cloacae S1 isolate expressing quinolone resistance determinant QnrB4 by E-test,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793030,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,32.0
42891,,2348500,CHEMBL960517,Antibacterial activity against Escherichia coli TOP10 by E-test,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793030,<,1,1,<,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
42892,,2348503,CHEMBL960518,Antibacterial activity against Escherichia coli TOP10 containing pS1B plasmid expressing quinolone resistance determinant QnrS1 by E-test,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793030,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
42893,,2351634,CHEMBL954735,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792939,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.12
42894,,2351635,CHEMBL954735,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792939,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.25
42895,,2351649,CHEMBL954736,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,792939,=,1,0,=,Activity,%,97.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,97.9
42896,,2351658,CHEMBL954737,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,792939,=,1,0,=,Activity,%,1.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,1.7
42897,,2421524,CHEMBL955097,"Antimycobacterial activity against Mycobacterium ulcerans isolate CU001 infected in BALB/c mouse left hind foot-pad assessed as bacterial load per culture-positive foot-pad at 100 mg/kg, po administered for 5 days per week measured after 4 weeks",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1153834,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,782877,=,1,0,=,log10cfu,,3.23,CHEMBL612965,Mycobacterium ulcerans,Mycobacterium ulcerans,1809.0,,log10cfu,,,3.23
42898,,2421528,CHEMBL955095,Antimycobacterial activity against Mycobacterium ulcerans isolate CU001,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1153834,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,782877,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612965,Mycobacterium ulcerans,Mycobacterium ulcerans,1809.0,,MIC,ug ml-1,UO_0000274,0.25
42899,,2421533,CHEMBL955870,"Antimycobacterial activity against Mycobacterium ulcerans isolate CU001 infected in BALB/c mouse left hind foot-pad assessed as bacterial load at 100 mg/kg, po administered for 5 days per week measured after 4 weeks",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1153834,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,782877,=,1,0,=,log10cfu,,2.99,CHEMBL612965,Mycobacterium ulcerans,Mycobacterium ulcerans,1809.0,,log10cfu,,,2.99
42900,,2421534,CHEMBL955868,"Antimycobacterial activity against Mycobacterium ulcerans isolate CU001 infected in BALB/c mouse left hind foot-pad assessed as bacterial load per culture-positive foot-pad at 10 mg/kg, po administered for 5 days per week measured after 8 weeks",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1153834,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,782877,=,1,0,=,log10cfu,,1.72,CHEMBL612965,Mycobacterium ulcerans,Mycobacterium ulcerans,1809.0,,log10cfu,,,1.72
42901,,2421535,CHEMBL955874,"Antimycobacterial activity against Mycobacterium ulcerans isolate CU001 infected in BALB/c mouse left hind foot-pad assessed as bacterial load at 100 mg/kg, po administered for 5 days per week measured after 8 weeks",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1153834,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,782877,=,1,0,=,log10cfu,,1.25,CHEMBL612965,Mycobacterium ulcerans,Mycobacterium ulcerans,1809.0,,log10cfu,,,1.25
42902,,2467389,CHEMBL991709,Antibacterial activity against Staphylococcus aureus ATCC 13709 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142457,Bioorg Med Chem,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,801575,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
42903,Not Active,2467408,CHEMBL992515,"Protective effect against Staphylococcus aureus ATCC 13709-induced bone infection in CD rat at 10 mg/kg, iv administered as single dose 2 days before bacterial challenge",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142457,Bioorg Med Chem,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,801575,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
42904,Not Active,2467409,CHEMBL993351,"Protective effect against Staphylococcus aureus ATCC 13709-induced bone infection in CD rat at 10 mg/kg, iv administered as single dose 1 hr before bacterial challenge",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142457,Bioorg Med Chem,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,801575,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
42905,Not Active,2467412,CHEMBL993352,"Protective effect against Staphylococcus aureus ATCC 13709-induced bone infection in CD rat at 10 mg/kg, iv administered as single dose 24 hrs after bacterial challenge",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142457,Bioorg Med Chem,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,801575,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
42906,,2469840,CHEMBL983526,Antibacterial activity against Staphylococcus aureus ATCC 13709 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142491,J Med Chem,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,801617,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
42907,Active,2469856,CHEMBL1025786,"Protective effect against Staphylococcus aureus ATCC 13709-induced bone infection in CD rat at 10 mg/kg, iv administered as single dose 1 hr after bacterial challenge",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142491,J Med Chem,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,801617,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
42908,,2469861,CHEMBL1025778,Binding affinity to bone assessed as drug level bound to cattle bone meal powder by fluorescence assay,B,BAO_0001103,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1142491,J Med Chem,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,801617,=,1,0,=,Activity,%,0.01,CHEMBL4296530,Bos taurus,Bone,9913.0,,Activity,%,UO_0000187,0.01
42909,,2495058,CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779483,<=,1,1,<=,MIC50,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.25
42910,,2495059,CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779483,<=,1,1,<=,MIC90,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.25
42911,,2495063,CHEMBL1028013,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,779483,=,1,0,=,Activity,%,2.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,2.4
42912,,2495079,CHEMBL1028014,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by CLSI breakpoint method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779483,>=,1,0,>=,Activity,ug ml-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,4.0
42913,,2495089,CHEMBL1028015,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent sensitive isolates by CLSI breakpoint method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779483,<=,1,0,<=,Activity,ug ml-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,1.0
42914,,2495096,CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779483,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
42915,,2498185,CHEMBL1030565,Antibacterial activity against Staphylococcus aureus RN4220 by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.064
42916,,2498186,CHEMBL1030566,Antibacterial activity against Staphylococcus aureus RN4220 containing ORI23 promoter by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.064
42917,,2498187,CHEMBL1030567,Antibacterial activity against Staphylococcus aureus RN4220 containing ORI23::qnr-cat promoter mutant by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
42918,,2498188,CHEMBL1030568,Antibacterial activity against Lactococcus lactis IL-1419 by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,MIC,ug ml-1,UO_0000274,0.25
42919,,2498189,CHEMBL1033151,Antibacterial activity against Lactococcus lactis IL-1419 containing ORI23 promoter by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,MIC,ug ml-1,UO_0000274,0.25
42920,,2498190,CHEMBL1020335,Antibacterial activity against Lactococcus lactis IL-1419 containing ORI23::qnr-cat promoter mutant by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,MIC,ug ml-1,UO_0000274,1.0
42921,,2498191,CHEMBL1020336,Antibacterial activity against Escherichia coli DH10B by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42922,,2498192,CHEMBL1020337,Antibacterial activity against Escherichia coli DH10B containing ORI23 promoter by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42923,,2498193,CHEMBL1020338,Antibacterial activity against Escherichia coli DH10B containing ORI23::qnr-cat promoter mutant by twofold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
42924,,2499758,CHEMBL992264,Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
42925,,2499780,CHEMBL992265,Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42926,,2499802,CHEMBL992266,Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
42927,,2499824,CHEMBL992267,Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42928,,2499846,CHEMBL992268,Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
42929,,2499868,CHEMBL992269,Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.002
42930,,2499890,CHEMBL992270,Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,779190,=,1,0,=,Ratio,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,8.0
42931,,2502732,CHEMBL1029674,Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780040,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
42932,,2502733,CHEMBL1029675,Antibacterial activity against methicillin-sensitive Staphylococcus aureus by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780040,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.032
42933,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2502734,CHEMBL1029676,"Cmax in Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po",A,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,780040,=,1,1,=,Cmax,nM,7099.44,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Cmax,mg/L,UO_0000065,2.85
42934,,2502735,CHEMBL1029677,"AUC (0 to 24 hrs) in Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po",A,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,780040,=,1,1,=,AUC,ng.hr.mL-1,37500.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,AUC,mg.hr/L,,37.5
42935,,2502736,CHEMBL1029678,"Half life in Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po",A,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,780040,=,1,1,=,T1/2,hr,8.2,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,t1/2,hr,UO_0000032,8.2
42936,,2502737,CHEMBL1029679,"Ratio of AUC (0 to 24 hrs) in Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po to MIC for methicillin-sensitive Staphylococcus aureus",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,780040,>,1,0,>,RatioAUC/MIC,,1000.0,CHEMBL612545,,Unchecked,,,RatioAUC/MIC,,,1000.0
42937,,2502738,CHEMBL1029680,"Ratio of Cmax in Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po to MIC for methicillin-sensitive Staphylococcus aureus",F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,780040,=,1,0,=,Ratio,,90.0,CHEMBL612545,,Unchecked,,,Ratio,,,90.0
42938,,2502740,CHEMBL1029682,"Ratio of Cmin in synovial fluid of Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po to MIC for methicillin-sensitive Staphylococcus aureus",F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,780040,=,1,0,=,Ratio,,121.0,CHEMBL612545,,Unchecked,,,Ratio,,,121.0
42939,,2502743,CHEMBL1029688,Antibacterial activity against ciprofloxacin and methicillin-resistant Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780040,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
42940,Active,2556436,CHEMBL993693,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 5 days",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42941,Active,2556439,CHEMBL993692,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 5 days",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42942,,2556468,CHEMBL990922,Antimicrobial activity against nonepidemic Clostridium difficile ATCC 9689 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,<,1,1,<,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
42943,,2556473,CHEMBL990923,Antimicrobial activity against nonepidemic Clostridium difficile J29 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,32.0
42944,,2556478,CHEMBL990924,Antimicrobial activity against epidemic Clostridium difficile BI9 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
42945,,2556483,CHEMBL990925,Antimicrobial activity against epidemic Clostridium difficile BI6-8-17 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
42946,,2556488,CHEMBL990926,Antimicrobial activity against fluoroquinolone-resistant epidemic Clostridium difficile NAP1 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,256.0
42947,,2556493,CHEMBL990927,Antimicrobial activity against fluoroquinolone-susceptible nonepidemic Clostridium difficile strain6 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
42948,Active,2556501,CHEMBL994406,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42949,Active,2556502,CHEMBL994407,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42950,Active,2556504,CHEMBL994409,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42951,Active,2556521,CHEMBL994410,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42952,Active,2556522,CHEMBL994411,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42953,Active,2556523,CHEMBL994412,"Effect on growth of epidemic Clostridium difficile BI9 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42954,Active,2556524,CHEMBL994413,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42955,Active,2556525,CHEMBL994414,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42956,Active,2556526,CHEMBL994415,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42957,Active,2556527,CHEMBL994417,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42958,,2556544,CHEMBL993691,Drug level in Clostridium difficile infected CF1 mouse stool at 0.2 mg/day for 4 days,A,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,=,1,0,=,Drug uptake,ug/g,44.0,CHEMBL612558,,ADMET,,,Drug uptake,ug/g,,44.0
42959,Not Active,2556557,CHEMBL993695,Effect on growth of fluoroquinolone-susceptible epidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content dosed sc for 5 days,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42960,Active,2556588,CHEMBL993694,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 2.0 mg/day, sc for 5 days",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743672,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
42961,,2575481,CHEMBL994364,"AUC (0 to 12 hrs) in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit at 20 mg/kg, iv administered every 12 hrs measured after seventh dose in presence of Dexamethasone",A,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,1,=,AUC,ng.hr.mL-1,23900.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,AUC,microg.hr/mL,,23.9
42962,,2575482,CHEMBL994369,"Toxicity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as fibrous content median score at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose by histopathology",T,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,Activity,,1.6,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Activity,,,1.6
42963,,2575483,CHEMBL994366,"Toxicity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as tissue valve damage median score at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose by histopathology",T,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,Activity,,2.3,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Activity,,,2.3
42964,,2575484,CHEMBL994368,"Toxicity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as collagenization median score at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose by histopathology",T,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,Activity,,2.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Activity,,,2.0
42965,,2575485,CHEMBL994370,"Toxicity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as calcification median score at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose by histopathology",T,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,Activity,,1.6,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Activity,,,1.6
42966,,2575486,CHEMBL994367,"Toxicity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as inflammatory cell infiltration median score at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose by histopathology",T,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,Activity,,1.2,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Activity,,,1.2
42967,Active,2575487,CHEMBL994365,"Cardiovascular activity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as increase in fractional shortening at 20 mg/kg, iv administered every 12 hrs for 5 days by ECG",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
42968,,2575492,CHEMBL993606,Antibacterial activity against Staphylococcus aureus by manual microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743503,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
42969,,2575493,CHEMBL993606,Antibacterial activity against Staphylococcus aureus by manual microdilution technique,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,MBC,mg/L,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,mg/L,,0.125
42970,,2575494,CHEMBL993608,Antibacterial activity against Staphylococcus aureus by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743503,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.064
42971,,2575495,CHEMBL993607,Antibacterial activity against Staphylococcus aureus at 0.5 mg/liter by time kill assay,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,>,1,0,>,log10CFU/ml,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,3.0
42972,,2575496,CHEMBL993609,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as number of survival days at 20 mg/kg, iv administered every 12 hrs for 5 days",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Day,743503,=,1,0,=,Survival,day,15.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Survival,day,UO_0000033,15.3
42973,,2575497,CHEMBL993611,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as reduction in bacterial burdens in blood culture at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 hrs after end of treatment",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,log10CFU/ml,,2.83,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,2.83
42974,Active,2575498,CHEMBL993612,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as cured animals in blood culture at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
42975,Active,2575499,CHEMBL993610,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as cured animals in blood culture at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 hrs after end of treatment",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
42976,,2575500,CHEMBL993613,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as reduction in bacterial burdens in blood culture at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,log10CFU/ml,mg/L,2.76,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,mg/L,,2.76
42977,,2575501,CHEMBL994358,"Concentration in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 30 mins after third dose",A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,Drug uptake,mg/L,3.73,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Drug uptake,mg/L,,3.73
42978,,2575502,CHEMBL994359,"Concentration in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 12 hrs after third dose",A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,Drug uptake,mg/L,0.23,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Drug uptake,mg/L,,0.23
42979,,2575503,CHEMBL994360,"AUC (0 to 12 hrs) in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit at 20 mg/kg, iv administered every 12 hrs measured after third dose",A,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,1,=,AUC,ng.hr.mL-1,16500.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,AUC,mg.hr/L,,16.5
42980,,2575504,CHEMBL994361,"AUC (0 to 12 hrs) in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit at 20 mg/kg, iv administered every 12 hrs measured after seventh dose",A,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,1,=,AUC,ng.hr.mL-1,22200.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,AUC,mg.hr/L,,22.2
42981,,2575505,CHEMBL994362,"Concentration in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 30 mins after seventh dose in presence of Dexamethasone",A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,Drug uptake,mg/L,3.33,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Drug uptake,mg/L,,3.33
42982,,2575506,CHEMBL994363,"Concentration in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 12hrs after seventh dose in presence of Dexamethasone",A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,Drug uptake,mg/L,1.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Drug uptake,mg/L,,1.0
42983,,2575509,CHEMBL994371,"Drug level in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 30 mins after seventh dose",A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,Drug uptake,mg/L,4.39,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Drug uptake,mg/L,,4.39
42984,,2575510,CHEMBL994372,"Drug level in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 12 hrs after seventh dose",A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,743503,=,1,0,=,Drug uptake,mg/L,0.51,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Drug uptake,mg/L,,0.51
42985,,2576492,CHEMBL988157,Antimicrobial activity against Clostridium difficile clinical isolates by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155149,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743071,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC50,ug ml-1,UO_0000274,1.0
42986,,2576493,CHEMBL988157,Antimicrobial activity against Clostridium difficile clinical isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1155149,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743071,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC90,ug ml-1,UO_0000274,16.0
42987,,2632653,CHEMBL963550,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,6.6,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,6.6
42988,,2632654,CHEMBL963549,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,6.53,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,6.53
42989,,2632655,CHEMBL963548,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,5.35,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,5.35
42990,,2632674,CHEMBL963544,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,4.15,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,log10cfu,,,4.15
42991,,2632675,CHEMBL963543,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,4.76,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,log10cfu,,,4.76
42992,,2632676,CHEMBL963542,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,4.83,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,log10cfu,,,4.83
42993,,2632677,CHEMBL963538,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,9.18,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,log10cfu,,,9.18
42994,,2632678,CHEMBL963537,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,9.68,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,log10cfu,,,9.68
42995,,2632679,CHEMBL963536,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,8.83,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,log10cfu,,,8.83
42996,,2632686,CHEMBL949908,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,7.9,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,7.9
42997,,2632687,CHEMBL998999,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,7.78,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,7.78
42998,,2632688,CHEMBL999000,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,783317,=,1,0,=,log10cfu,,7.39,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,log10cfu,,,7.39
42999,,2632698,CHEMBL962730,Antimycobacterial activity against Mycobacterium avium JATA51-01 after 14 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783317,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC,ug ml-1,UO_0000274,2.0
